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ABSTRACT
Despite considerable evidence to support efficacious and effective intervention
for single health behaviors, relatively little is known about simultaneous multiple health
behavior change. This research analyzed multiple health behavior change for three very
different health risk behaviors. The sample (N=9,461) was predominantly White
(93.8%), middle-aged (X= 43.9 years-old, SD=10.74) adults who met criteria for
smoking, unhealthy diet, and unprotected sun exposure. Specifically, when sun
protection and diet, smoking and diet, and smoking and sun protection were analyzed as
three sets of behavior pairs from baseline to 24-month follow-up, results consistently
demonstrated that simultaneous intervention on multiple health behavior risks increased
the likelihood that participants moved to criteria on both behaviors. More specifically,
across all the behavior pair analyses and treatment conditions, 70 out of the 71 odds ratios
revealed that participants were more likely to meet criteria on both behaviors compared
to participants who only met criteria on the second behavior. Overall, results provide
empirical support for the advantages of simultaneous intervention for multiple health
behavior change as paired action, co-progression, and reduction on severity was observed
across treatment conditions. Finally, results provide empirical support for shifting the
fundamental unit of analysis from separate behaviors at outcome to behavior pairs at
outcome and to use dynamic variables to help elucidate the science of behavior change.
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CHAPTER 1
INTRODUCTION
Although research has advanced clinical science in some areas, other areas
continue to lag. For example, despite considerable evidence to support efficacious and
effective intervention for single health behaviors, relatively little is known about multiple
health behavior change. Moreover, simultaneous intervention on multiple health
behavior risks challenges the dominant separate behavior paradigm which evaluates
interventions based on single behavior outcomes as the fundamental unit of analysis in
order to establish intervention efficacy and effectiveness.
In response to the growing demands for more rigorous evaluation of intervention
efficacy, effectiveness, and cost efficiency, multiple health behavior change holds
considerable promise for the future of intervention and prevention research and practice.
Moreover, multiple health behavior change is important because certain populations are
among the greatest risk for chronic disease, disability, and premature death (Prochaska,
2008) and because of the increased prevalence of obesity and sedentary lifestyles in the
United States. So, although behavioral interventions have long demonstrated to be
critical, cross-cultural, and cost-effective factors germane to the development and
prevention of numerous medical conditions including cardiovascular disease and some
cancers, it remains unclear how simultaneous intervention on multiple health behavior
risks fares when the fundamental unit of analysis is shifted from separate behaviors at
outcome to behavior pairs at outcome. Such a shift is important because doing so may
reveal synergistic effects currently undetected by the dominant separate behavior
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paradigm and its analytic approaches, in addition to advancing the knowledge-base and
scientific evaluation of behavioral interventions for multiple health behavior change.
Given the direct and considerable impact of health risks on mortality, quality of
life, and health care costs, in combination with the cutting edge research on multiple
health behavior change, the following research is important because it serves to: 1)
promote population-based health and wellness; 2) understand the underlying mechanisms
and interrelationships of effective intervention for multiple health behavior change; and
3) help elucidate the science of behavior change. Moreover, this research will advance
the current knowledge-base in intervention and prevention research, possibly provide an
empirical basis to shift the dominant separate behavior paradigm, and help guide the
future of intervention and prevention research and practice toward an integrative model
of multiple health behavior change.
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CHAPTER 2
REVIEW OF LITERATURE
Intervention is a broad enterprise replete with myriad aims and goals. Although
specification of a treatment and evaluation of its feasibility and efficacy are of central
importance (Kazdin, 2003), equally important are considerations about its’ effectiveness,
cost-efficiency, and potential for iatrogenic effects. Considered together, these distinct
aims can be coalesced into a larger, more comprehensive analysis known as treatment
evaluation (Nelson & Steele, 2006). This framework is not only part of the impetus
behind the evidenced-based practice (EBP) movement in psychology, but also part of the
larger scientific zeitgeist calling for more precise and methodologically rigorous research.
Toward that aim, the Transtheoretical Model (TTM) (Prochaska & DiClemente, 1983)
has emerged as an important advancement in behavioral intervention by establishing
strong empirical support for effectively intervening on more than 48 problem behavioral
areas by providing individually and expertly tailored, stage-based interventions based on
an individual’s stage of change (Hall & Rossi, 2008).
The TTM is an integrative model of intentional behavior change centrally
organized around the temporal Stage of Change (SOC) dimension (Prochaska &
DiClemente, 1983). Specifically, the TTM is comprised of five stages of change:
Precontemplation (i.e., PC- not intending to take action in the next six months),
Contemplation (i.e., C- intending to action in the next 6 months), Preparation (i.e., PRintending to take action in the next thirty days), Action, (i.e., A- there has been an overt
behavior change which has not been maintained for six months), and Maintenance (i.e.,
M- a behavior change has been maintained for at least six months). Essentially, SOC
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describe the processes through which behavior change occurs in individuals or
populations (e.g., smokers) over time. Critical to behavior change is that movement
through the SOC varies as some people remain in a certain SOC for a period of time
while others may relapse to earlier stages before behavioral change goals are met
(Prochaska, Redding & Evers, 2008). In addition to SOC, there are several other
constructs central to the TTM.
Decisional Balance (DB) is the construct that refers to the Pros and Cons of
behavior change (Velicer, DiClemente, Prochaska & Brandenberg, 1985). Specifically,
this construct refers to an individual’s perception about the relative weights about making
behavior change (Velicer et al, 1985); the benefits of a behavior change are labeled Pros,
whereas the costs of a behavior change are labeled Cons. For example, a Pro of quitting
smoking may be reduced cancer risk or saving money, whereas a Con may be concerns of
weight gain or experiencing nicotine withdrawal symptoms. DB is important as it has
been shown to be particularly useful in predicting movement through the SOC
(Prochaska, Velicer & Rossi, 1994), and because the relationship between the Pros and
Cons has been replicated across 48 problem areas (Hall & Rossi, 2008). An outgrowth of
this consistent pattern across multiple problem areas is referred to as the strong and weak
principles (Prochaska, 1994). The former states that progression from PC to A is a
function of approximately one standard deviation increase in the Pros of a health
behavior change, while the latter states that progression from PC to A is a function of
approximately a half standard deviation decrease in the Cons of a health behavior change.
Although this relationship has been replicated across a variety of single behaviors, little is
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known about the relationship between DB and simultaneous multiple health behavior
change.
Self-Efficacy (SE) is the construct that refers to the situation specific confidence
an individual has to cope with high risk situations or temptations (Velicer, DiClemente,
Rossi & Prochaska, 1990). Similar to DB, SE has been shown to be particularly
important to predicting movement through the SOC. Specifically, Velicer, DiClemente,
Rossi & Prochaska (1990) found that individuals in earlier SOC (i.e., PC/C) typically
report lower confidence in a behavior change as compared to those individuals who are in
later SOC (i.e., A/M). This finding suggests that an individual’s SE increases as the
individual progresses through the TTM. However, with regard to multiple health
behavior change specifically, little is known whether increasing an individual’s SE on
one behavior leads to an increase in the individual’s SE on a second behavior. Thus,
although the TTM has established efficacy and effectiveness for intervening on numerous
single health behaviors (e.g., smoking cessation, diet, unprotected sun exposure), little is
known whether and how TTM intervention affects multiple health behavior change
simultaneously.
Processes of Change (POC) is the construct that refers to the covert and overt
strategies and techniques people use to alter their experiences and environment to
progress through the various SOC (Prochaska, Velicer, DiClemente & Fava, 1988). By
integrating various theoretical orientations (e.g., psychodynamic, social-learning), the
TTM has derived ten POC comprised of two higher order constructs that are either
experiential or behavioral in nature. The five experiential processes are: Consciousness
Raising, Dramatic Relief, Social Liberation, Self-reevaluation, and Environmental
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Reevaluation (Prochaska, Velicer, DiClemente & Fava, 1988). The five behavioral
processes are: Stimulus Control, Helping Relationships, Reinforcement Management,
Self-liberation, and Counter Conditioning (Prochaska, Velicer, DiClemente & Fava,
1988). Interestingly, Prochaska, Velicer, DiClemente, Guadagnoli, & Rossi (1991) found
that the use of each POC was highly related to an individual’s SOC. Specifically, they
found that experiential POC (e.g., Consciousness Raising) were emphasized at earlier
SOC (i.e., PC/C), whereas behavioral POC (e.g., Helping Relationships) were
emphasized at later SOC (i.e., A/M). With regard to multiple health behavior change,
however, little is known about how movement through the SOC on one behavior is
related to movement through the SOC on a second behavior.
For example, do smokers who make stage progress toward smoking cessation
(i.e., PC-C or C-PR) but not to Action criteria also make stage progress on other health
behaviors associated with improved health outcomes such as diet, exercise, or
unprotected sun exposure? Or, is it that individuals remain stable or possibly regress to
an earlier SOC on a different problem area because of the difficulty associated with
behavior change? In addition to these important yet unanswered questions, research has
revealed how issues of multiculturalism and diversity are also essential considerations
when evaluating stage and population-based behavioral intervention for health behavior
risks. Specifically, research has shown that diverse groups have different baseline
staging for various health behaviors. In addition, research has also revealed that certain
groups are at more risk than other groups to engage in multiple health behavior risks.
Given these findings, group membership with regard to sex, gender, age, race, sexual
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orientation, and religious affiliation are important factors when assessing and intervening
with stage-based behavioral intervention.
Blum et al. (2001) found that White adolescents were more likely to smoke
cigarettes, drink alcohol, and attempt suicide in younger years than Black and Hispanic
youth, but that Black youths were more likely to engage in sexual intercourse while
Black and Hispanic youths were both more likely than White adolescents to engage in
violence. When considering sexual orientation and adolescents, Garofalo, Wolf, Kessel,
Paslfrey, & DuRant (1998) found that gay, lesbian, and bisexual (GLB) youth were more
likely than their peers to have been victimized and threatened and to have engaged in a
variety of health risk behaviors including suicidal ideation and attempts, multiple
substance use, and sexual risk behaviors.
In a 30-year longitudinal study on religious affiliation and health behaviors,
Strawbridge, Shema, Cohen, & Kaplan (2001) found that weekly religious attendance
reduced severity on health risk behaviors and helped maintain good health behaviors,
while also improving and maintaining good mental health, increased social relationships,
and marital stability with stronger effects for women than men. Similarly, and specific to
sex and gender differences for sunscreen use and diet, Weinstock, Rossi, Redding,
Maddock & Cottrill (2001) found women were more likely than men to engage in sun
protective behaviors, while Campbell et al. (1999) found that women more likely than
men to be in the Action/Maintenance (i.e., A/M) stage for fruit and vegetable
consumption.
With respect to independent baseline predictors and group-level patterns of
alcohol use, Brennan, Schutte, & Moos (2010) found that although males tend to have
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and maintain more problems associated with alcohol consumption than females across
the lifespan, the single strongest predictor of 10-year drinking trajectories was baseline
alcohol consumption in excess of recommended drinking guidelines for older adults,
regardless of sex, gender, race, or socioeconomic status. Furthermore, these findings are
consistent with previous research that revealed heavier initial drinking predicts steeper
decline in subsequent alcohol use in both mixed-aged and older populations (Kerr et al.,
2004; Moore et al. 2005).
Despite the importance of demographic variables such as race, ethnicity, gender,
age, socioeconomic status and education level on baseline staging, demographic variables
have not been shown to be reliable predictors of treatment outcome. For example, with
smoking outcomes across five studies, Velicer, Redding, Sun, & Prochaska (2007) found
no significant differences across gender, race, and ethnicity; however, they did find a few
significant findings and small effect sizes for age and education subgroups. Similarly,
with smokers, Redding et al. (2011) also found that behavior changes were not
consistently related to demographic variables and group membership. Instead, they
found significant small-to-medium-sized differences between stable smokers from
maintainers/relapsers based on baseline SOC, problem severity, and effort. Overall, the
consistent finding that gender is not a significant variable for smoking cessation was part
of the Surgeon General’s Report (U.S. Department of Health & Human Services, 2011)
concluding that, “cessation interventions are generally of similar effectiveness to women
and men and, to date, few gender differences have been identified” (p. 8).
With regard to race, ethnicity, and smoking cessation, Velicer et al. (2007) found
a lack of significant relationships between these baseline variables and treatment
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outcome. Specifically, with effect sizes were near zero for race and small effect sizes for
ethnicity, they concluded that tailored behavioral intervention is about equally effective
across racial and ethnic subgroups. Research in addictions has further shown that
problem severity such as time to first cigarette in the day (i.e., Fagerstrom’s Index) is
inversely related to success across demographics (Falba, Jofre-Bonet, Busch, Duchovney,
& Sindalar, 2004). Including demographic variables other than gender, race, and
ethnicity, Sheeran’s (2002) meta-analysis across multiple health behaviors confirmed that
intention to change (i.e., SOC in TTM) is vital to promoting change, but that intention
alone is insufficient to predict outcome as only 47 percent of those with positive intention
to take Action on a behavior actually did take Action; that is, move to healthy criteria.
When specifically analyzing smoking, diet, and unprotected sun exposure,
Blissmer et al. (2010) also found that demographic variables were not reliable predictors
of treatment outcome. However, what they did find is that four effects do reliably predict
treatment outcome. Specifically, as measured by decisional balance (DB), processes of
change (POC), and self-efficacy (SE), Blissmer et al. (2010) found that 1) treatment, 2)
baseline SOC, 3) addiction severity, and 4) effort all predicted treatment outcome during
multiple health behavior change. Interestingly, the largest effect sizes were observed
with the SOC, followed by SE, treatment, and effort, respectively. Similar to previous
findings, they also found that demographic variables had the smallest effect sizes.
Ultimately, this suggests that static variables at baseline such as demographics do not
predict treatment outcome and, in contrast, that dynamic variables do predict treatment
outcome. Therefore, the dynamic variables of SOC, DB, and problem severity are
important when investigating multiple health behavior change as they have been shown
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to be among the best predictors of treatment outcome. Moreover, these findings further
suggest that dynamic variables are among the most salient factors relevant to health
behavior change and that, perhaps, they are among the most important variables to help
elucidate the science of multiple health behavior change.
Given the intricacies of behavior change, and some of the inherent difficulties
with behavioral health research, the dominant paradigm of intervention and prevention
research has been to intervene on a problem area by first establishing a baseline criteria,
then measure that behavior at intervention outcome and, ideally, at some follow-up time
point. A natural and logical outgrowth of this approach has been, historically, for
interventions to report outcome criteria on separate behaviors in order to establish
intervention efficacy and effectiveness, independent from its possible effect on other
problem areas. For example, smoking cessation interventions are considered efficacious
(i.e., internal validity) if and only if the intervention leads to the individual meeting an
abstinence criterion for smoking at outcome and at some follow-up time point.
Conversely, interventions are considered to lack efficacy if they do not lead to an
individual meeting the abstinence criterion at whether at outcome or at follow-up.
In contrast to abstinence-based outcomes, motivational interviewing (MI; Miller
& Rollnick, 1995; 2002) and other harm reduction models have emerged to show that
although individuals may not meet a stringent abstinence criterion on a problem area
(e.g., alcohol), interventions that reduce behavioral risks are nonetheless clinically useful
and help accelerate individuals toward reduced risk and healthier outcomes.
Additionally, and similar to finding with the TTM, MI has also demonstrated that certain
changes within individuals during an intervention can predict their behavior change at
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future time points. For example, Baer et al. (2008) demonstrated how client change talk
(i.e., CT) during brief, 15-minute MI interviews can significantly and prospectively
predict behavioral changes in substance use at 1 and 3-month follow-up.
Amrhein et al. (2003) demonstrated how commitment strength (CS), defined as
desire, readiness, and reasons to change, during intervention can predict reduced
substance use at 3 and 6-month follow-up. In their analyses, they also identified three
specific patterns of substance abuse users: maintainers, changers, and strugglers. In
Amrhein et al.’s research, maintainers referred to those participants who remained active
users, changers were those participants who took action toward cessation or reduced use,
and strugglers were those participants who frequently relapsed; similar to the pattern
found in the Redding et al. study. Although MI has demonstrated efficacy and
effectiveness for severity reduction and behavior change for a variety of substance abuse
and addictive behaviors (e.g., alcohol), particularly for resistant individuals (i.e., PC in
the TTM), MI has also has targeted separate behaviors and analyzed separate behaviors
as the fundamental unit of analysis. Therefore, despite MI helping to advance the
literature for health behavior risks and single behavior change, it has not advanced
multiple health behavior change. So, despite its many advances and contributions, MI is
also limited in its empirical contribution to this area.
Multiple health behavior change is critical as certain populations are among the
greatest risk for chronic disease, disability, and premature death (Prochaska, 2008).
Among tobacco users, for example, it is estimated that approximately 92% also meet
criteria for at least one additional risk behavior such as heavy alcohol drinking, physical
inactivity, or low consumption of fruits and vegetables (Pronk et al., 2004; Klesges, Eck,
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Isbell, Fulliton & Hanson, 1990). However, with over 6,000 studies on smoking
cessation (Fiore, 2000), there remains a paucity of research that evaluates intervention for
simultaneous multiple health behavior change despite the well established association
between health behavior risks and other problem areas. Taken together, although there is
considerable and compelling research on behavioral intervention for smoking, diet, and
unprotected sun exposure as separate behaviors, there are many notable gaps in the
literature for simultaneous intervention on multiple health behavior risks. This is
important because smoking, diet, and unprotected sun exposure are not only the most
prominent lifestyle factors associated with cardiovascular disease, diabetes, and some
cancers, they are also among the top causes of preventable deaths in the United States.
Given the growing need for multiple health behavior change, research has
recently started to address the efficacy and effectiveness of behavioral interventions
designed to simultaneously change two or more targeted health behavior risks
(Prochaska, 2008). That is, research has recently shifted toward understanding the
particular interrelationships among health behaviors and the interventions designed to
promote change in more than one health behavior risk simultaneously (Prochaska,
Spring, & Nigg, 2008). Toward this end, Paiva (2012) recently defined co-action of
behavior change as the extent to which change on one behavior is associated with change
on a second behavior at the same follow-up time point. With multiple health behavior
change specifically, Paiva et al. (2012) found that individuals in the treatment condition
who progressed to Action/Maintenance on one behavior were more likely to progress on
a second behavior compared to those participants in the same treatment condition group
who did not move to Action/Maintenance on the first behavior. These preliminary
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findings are important as they begin to explore the intricacies of simultaneous change of
multiple health behaviors, but additional research is necessary to further refine the current
knowledge base.
At present, the science of multiple health behavior change is in its nascent stages.
As such, many important questions remain unclear or unanswered. For example, how
exactly does effective change on one behavior affect change on a second behavior? If
individuals take Action on one behavior, is this related to taking effective Action on a
second behavior (i.e., co-action), do they progress toward Action on both behaviors (i.e.,
paired action), do they make stage progress toward Action but do not meet Action criteria
(i.e., co-progression), or do they remain stable, or possibly even regress to earlier stages
of change? Ultimately, because these questions all aim to identify and elucidate the
interrelationships among behavior change, co-variation can be used to describe the
broader construct of co-action, paired action, and co-progression. Specifically, covariation may be considered the broader construct as co-action, paired action, and coprogression may well be conceptualized as three different types of co-variation.
However, given the specific definitions for co-action, paired action, and co-progression in
the literature, this research will adhere to the definitions provided in the literature and
define movement to Action criteria on a second behavior as co-action (Paiva, 2012), and
define stage progress, increases on DB, and reduced severity as co-progression.
Additionally, it is not clear whether there are any synergistic effects during
multiple health behavior change and, if so, whether these effects are specific to the
treatment condition or if they naturally occur in the control condition as a natural
outgrowth of multiple health behavior change. Moreover, it remains unclear whether and
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how multiple health behavior change may vary by different behavior pairs. For example,
it is possible that there are differences when addictive behaviors (e.g., smoking) are
paired together with non-addictive behaviors (i.e., unprotected sun exposure, exercise).
Finally, it also remains unclear how paired action (i.e., changes in both behaviors of a
pair), singular action (i.e., change in only a single behavior of a pair), and total action
(i.e., changes in a full set of behaviors that is expected to produce synergy with the
changes in untreated behaviors but only when a tipping point is reached in terms of the
magnitude of change in treated behaviors per participant) (Prochaska et al., 2011) relates
to multiple health behavior change when the fundamental unit of analysis is changed
from separate behaviors at follow-up to behavior pairs at follow-up.
The consistent findings with SOC, DB, problem severity (e.g., dynamic variables)
and treatment outcome for separate behaviors has lent considerable support to the TTM’s
focus on stage and stage progress particularly during the initial phase of intervention
(Velicer et al., 2007). However, relatively little is known about the interrelationships of
the dynamic variables and multiple health behavior change. Therefore, even less is
known about how defining success as: 1) movement to A/M on both behaviors, 2)
reduction on severity on both behaviors, or 3) accelerating participants through the SOC
on both behaviors may affect and predict treatment outcomes.
The justification for this study’s hypotheses is based on the TTM’s definition of
change as stage progress and success as progressing to A/M criteria, the phenomenon of
co-action and co-progression, the consistent findings that dynamic (i.e., not static)
variables reliably predict treatment outcome, as well as the clinical value and utility of
severity reduction on health risk behaviors. Specifically, investigating paired action and
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co-progression to reveal how SOC, DB, and problem severity affect multiple health
behavior change is important because these dynamic variables have proven to be among
the best predictors of treatment outcome within the paradigm of separate behavior
change. Therefore, investigating how baseline SOC, the Pros and Cons of behavior
change (i.e., DB), and problem severity relates to multiple health behavior is especially
important in order to help establish an empirical basis to answer existing questions and
guide future research. Finally, these hypotheses may also help guide the future of
behavioral health intervention and prevention research to shift from the dominant
paradigm of separate behavior change and embrace an integrative model of multiple
health behavior change.
The specific hypotheses for this project are:
H1) Participants in Contemplation (C) or Preparation (PR) at baseline for two
behaviors will be more likely to move to criteria (Action/Maintenance) on both behaviors
at final follow-up (i.e., paired action) than participants who are in Precontemplation (PC)
at baseline for both behaviors.
H2) Participants who make stage progress (i.e., progress at least one stage) on one
behavior will also make stage progress on a second behavior, with more co-progression
observed in the treatment than the control group.
H3) Participants who decrease their severity by a defined amount on one behavior
will also decrease their severity on a second behavior, with more co-progression observed
in the treatment than the control group.
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H4) Participants who increase their Pros and Cons by a defined amount on one
behavior will do the same for a second behavior, with more co-progression observed in
the treatment than the control group.
H5) As an exploratory approach, it is expected that participants who move to
Action/Maintenance on only one behavior will also show smaller signs of success as
defined by: a) making stage progress on a second behavior, b) decreasing severity on a
second behavior; and c) increasing their Pros and decreasing their Cons on a second
behavior. It is also expected that these changes will be observed in the treatment group
more than in the control group.
H6) Paired action and co-progression are not expected to vary by race or gender.
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CHAPTER 3
METHODOLOGY
This research was a secondary data analysis that investigated multiple health
behavior change, co-action, paired action, and co-progression using the Transtheoretical
Model. Data used for this project were drawn from a National Cancer Institute (NCI)funded center grant (P01; CA27821, Principle Investigator, Prochaska) that assessed the
effectiveness of home, school, worksite, and medical practice-based prevention programs
designed to reduce multiple behavior risks for cancer. Specifically, this P01 evaluated
the effectiveness of stage-matched, interactive, computer-tailored intervention (CTI)
designed to accelerate individuals through each of the five Stages of Change (SOC) for
multiple health risk behaviors: diet (i.e., high fat and low fiber diets), unprotected sun
exposure, smoking, sedentary lifestyle, and adherence to breast cancer screening
recommendations over a five-year period with several assessment time points.
Additional details of this grant including, but not limited to, primary and secondary aims,
inclusion and exclusion criteria for participants, measures, and continuous IRB approval
are available for further review. The following research project includes analyses on the
health behavior risks of smoking, diet, and unprotected sun exposure and, specifically,
analyzes the behavior pairs: sun protection and diet, smoking and diet, and smoking and
sun protection.
The primary aim of this research was to elucidate multiple health behavior change
during stage-based, interactive and computer-tailored intervention (CTI) for multiple
health risk behaviors with the goal of broadening the phenomenon of co-action to include
a series of smaller changes deemed clinically important. Specifically, this study analyzed
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the behavior pairs 1) sun protection and diet, 2) smoking and diet, and 3) smoking and
sun protection to reveal paired action and co-progression rates in order to answer some of
the important, yet unanswered, questions about multiple health behavior change.
There were also several secondary aims of this study. First, this study was
designed to help promote population health and wellness by advancing the knowledge
base about intervention efficacy and multiple health behavior change by targeting a few
of the most prominent lifestyles risk factors (e.g., smoking, diet, unprotected sun
exposure) associated with preventable deaths in the United States including
cardiovascular disease and some cancers (e.g., lung). Second, this study was designed to
help elucidate the science of behavior change by revealing how the Stages of Change
(SOC) and the mathematical relationship of decisional balance (DB) relates to multiple
health behavior change. Third, this study aimed to provide an empirical basis to possibly
shift the dominant separate behavior paradigm and, in so doing, help guide the future of
intervention and prevention research and practice toward an integrative model of multiple
health behavior change.
Participants
Participants of the study were adults in the United States proactively recruited by
telephone. Upon telephone contact, prospective participants were screened in order to
satisfy explicit inclusionary criteria and be sure they did not meet exclusionary criteria.
The sample (N=9,461) was comprised of parents of adolescents who were participants in
a school-based study, patients from a health insurance provider, and employees from 22
identified worksites. Participants were predominantly middle-aged (X= 43.9 years-old,
SD=10.74), White (93.8%), and female (65.4%). All participants were assessed at

18

baseline and at 6-month intervals through 30 months post-intervention. Additional
details on the inclusion and exclusion criteria as well as the specific Procedures for each
project within the P01 were determined by each principle investigator (PI) and are
available on the original grant.
Measures:
Demographics:
Single items were used to assess age, gender, education, ethnicity, marital status
and perceived general health.
Stage of Change:
Smoking: SOC was measured by a staging algorithm that assessed participants’
readiness to quit smoking with response options of 1=Precontemplation (i.e., PC- not
intending to quit smoking in the next six months), 2=Contemplation (i.e., C- intending to
quit smoking in the next six months), 3=Preparation (i.e., PR- intending to quit smoking
in the next thirty days), 4=Action, (i.e., A- quit smoking less than six months ago), and
5=Maintenance (i.e., M- quit smoking more than six months ago).
Diet: SOC was assessed in a 3-step process. First, intention was assessed by the
following question, “Do you consistently avoid eating high-fat foods?” Subjects
responding “No” were assigned to either: a) Precontemplation– “No, and I do not intend
to in the next 6 months”; b) Contemplation– “No, but I intend to in the next 6 months; or
c) Preparation– “No, but I intend to in the next 30 days.” Second, subjects responding
“Yes,” must have met a behavioral criterion of estimated fat intake ≤ 30% calories (based
on the Dietary Behavior Questionnaire) to be classified into Action– "Yes, but for less
than 6 months" or Maintenance– "Yes, for more than 6 months." Third, subjects who

19

perceived that they consistently avoid high fat foods, but fail to meet the behavioral
criterion were classified into Precontemplation, Contemplation, or Preparation based on
intention to change eating habits (Greene et al., 1999).
Sun Exposure:
Decisional Balance, Self-Efficacy, and Problem Severity: Table 1.
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Table 1: Decisional Balance, Self-Efficacy, and Problem Severity: Smoking, Diet, and Sun Exposure.

Number of Items

Response Options Reliability

Reference

1=“Not At All
Important” to
5=“Extremely
Important”
1=“Not At All
Important” to
5=“Extremely
Important”

Pros
(α=.87)
Cons
(α=.90)
Pros (α =
.52)
Cons (α =
.47)

Velicer, DiClemente,
Prochaska, &
Brandenburg, 1985

1=“Not At All
Tempted” to
5=“Extremely
Tempted”
1=“Not At All
Tempted” to
5=“Extremely
Tempted”

α=

Velicer, DiClemente,
Rossi, & Prochaska,
1990

α = .71

Greene et al.,
2001;Greene et al.,
1999; Prochaska et al.,
1994; Rossi et al.,
1994b; Rossi, Rossi, &
Hargreaves, 1997

Continuous
measures:
number of
cigarettes time to
first cigarette
Previous month:
1=“Never” to
5=“Almost
Always”

n/a

Fagerstrom,
Heatherton, &
Kozlowski, 1990

α ranges
from 0.67
to 0.84

Greene et al., 1996

Decisional Balance
Smoking

4 Pros of quitting
4 Cons of quitting

Diet

3 Pros of high fat
diet
3 Cons of high fat
diet

Greene, Rossi, Rossi,
Fava et al.,
2001;Greene, Rossi,
Rossi, Velicer et al.,
1999; Prochaska et al.,
1994; Rossi et al.,
1994b; Rossi, Rossi, &
Hargreaves, 1997

Sun Exposure

Self-Efficacy
Smoking

9 situational
temptations

Diet

9 situational
temptations

Sun Exposure

Problem Severity
Smoking

2 items

Diet

Dietary Behavior
Questionnaire:
22-items (4
subscales)

Sun Exposure
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Data Analytic Strategies
The primary and secondary aims of this study were achieved by the following
analyses. The first set of analyses ran descriptive statistics and bivariate plots to
determine whether the assumptions of the general linear model (GLM) were met and to
assess any issues with non-normal data including skewness, kurtosis, and missing data.
Although logistic regression (LR) does not require GLM assumptions to be met,
preliminary analyses were critical to ensure LR was an appropriate, and perhaps optimal,
statistical method for this research. Were there missing data, multiple imputation (MI)
would have been utilized as it has been shown to be the most reliable estimation of
missing data values.
H1) Participants in Contemplation (C) or Preparation (PR) at baseline for two
behaviors will be more likely to move to criteria (Action/Maintenance) on both behaviors
at final follow-up (i.e., paired action) than participants who are in Precontemplation (PC)
at baseline for both behaviors.
Analysis 1: A series of logistic regression (LR) analyses determined whether
being in later SOC (i.e., C and PR) at baseline for two behaviors was predictive of more
stage related paired action as compared to participants in PC at baseline. Predictors were
assessed at baseline and 24-month follow-up. Behavior pairs were examined within the
treatment and control groups separately, resulting in 6 LR analyses.
LR was performed to see how well one categorical, independent variable
predicted membership of a dichotomous dependent variable. Specifically, LR compared
the odds of moving to A/M on both behaviors in the behavior pair at 24-month follow-up
given the participant was either in PC or C/PR for both behaviors at baseline. Therefore,
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results show the participants who progressed to criteria as well as the odds ratios of
progressing to A/M on both behaviors at 24-month follow-up based on whether the
participant was in PC or C/PR for both behaviors at baseline by treatment condition.
The independent variables were analyzed by the behavior pairs: 1) sun protection
and diet, 2) smoking and diet, 3) smoking and sun protection. Specifically, the dataset
was categorized to identify participants who were in PC for both behaviors at baseline
and participants who were in either C or PR for both behaviors at baseline. Participants
who were in PC for both behaviors were categorized with a 0 (i.e., ‘being in PC for both
behaviors’) and participants who were in either C or PR for both behaviors were
categorized with a 1 (i.e., ‘being in Contemplation or Preparation for both behaviors’).
The dependent variables were analyzed by the same behavior pairs: 1) sun
protection and diet, 2) smoking and diet, 3) smoking and sun protection and SOC for both
behaviors at 24-month follow-up. Specifically, the dataset was categorized to identify the
participants who were in A/M for both behaviors in the behavior pair at 24-month followup and the participants who were not in A/M for both behaviors in the behavior pair at
24-month follow-up. Participants who did not move to A/M on both behaviors at 24month follow-up were categorized with a 0 (i.e., ‘did not change on both behaviors’) and
participants who did move to A/M on both behaviors at 24-month follow-up were
categorized with a 1 (i.e., ‘changed on both behaviors’).
After running each LR, a series of crosstabulations was conducted in order to
identify the specific number of participants who were in PC for both behaviors at baseline
and who moved to A/M on both behaviors at 24-month follow-up and the specific
number of participants who were in C/PR for both behaviors at baseline and moved to
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A/M on both behaviors at 24-month follow-up by treatment condition. As such, the
reported proportions reflect the percentage that number of participants represents relative
to all the participants who progressed to A/M on both behaviors at follow-up given they
were either in PC or C/PR at baseline for that treatment condition and not relative to the
total sample of the study. In addition, conditional confidence intervals were calculated
for each proportion of each behavior pair analysis. Therefore, the reported proportions
allow for a direct comparison between treatment and control conditions.
H2) Participants who make stage progress (i.e., progress at least one stage) on one
behavior will also make stage progress on a second behavior, with more co-progression
observed in the treatment than the control group.
Analysis 2: A series of LR analyses evaluated the likelihood of whether making
stage progress on one behavior increases the likelihood of making stage progress on a
second behavior, and assessed any differences between the treatment and control groups.
Behavior pairs were examined within the treatment and control groups separately,
resulting in 6 LR analyses.
LR was performed to see how well one categorical, independent variable
predicted membership of a dichotomous dependent variable. Specifically, in this
analysis, LR compared the odds of participants making stage progress on a second
behavior given stage progress on the first behavior compared to the odds of participants
making stage progress on the second behavior given no stage progress on the first
behavior from baseline to 24-month follow-up. Therefore, the results show the
participants and odds of making stage progress on both behaviors from baseline to 24month follow-up compared to the odds of making stage progress only on the second
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behavior not having made stage progress on the first behavior from baseline to 24-month
follow-up.
The independent and dependent variables were analyzed by the same behavior
pairs: 1) sun protection and diet, 2) smoking and diet, 3) smoking and sun protection and
SOC at baseline and at 24-month follow-up by treatment condition. Specifically, each
behavior within the pair was dichotomized into participants who did and did not progress
at least one SOC from baseline to 24-month follow-up on each behavior in the behavior
pair. Participants who did not progress at least one SOC were categorized with a 0 (i.e.,
‘stable/regress’) and participants who did progress at least one SOC from baseline to 24month follow-up were categorized with a 1 (i.e., ‘stage progress’); with the first behavior
in the behavior pair as the independent variable and the second behavior in the behavior
pair as the dependent variable. All analyses were run separately for the control,
treatment, and total conditions.
After running each LR, a series of crosstabulations was conducted in order to
identify the specific number of participants who made stage progress on the first behavior
at 24-month follow-up and whether the participant also made stage progress on the
second behavior at 24-month follow-up by treatment condition. As such, the reported
proportions reflect the percentage of participants who made stage progress on the second
behavior given they made stage progress on the first behavior compared to participants
who made stage progress on the second behavior not having made stage progress on the
first behavior in the behavior pair relative to that treatment condition. Again, conditional
confidence intervals were calculated for each proportion for each behavior pair by
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treatment condition. Therefore, results allow for a direct comparison of the treatment and
control conditions.
H3) Participants who decrease their severity by a defined amount on one behavior
will also decrease their severity on a second behavior, with more co-progression observed
in the treatment than the control group.
Analysis 3: A series of LR analyses evaluated the likelihood of whether reduction
in severity on one behavior increased the likelihood of reduction of severity on a second
behavior, and to assess any differences between the treatment and control groups. See
appendix 1.
LR was performed to see how well one categorical, independent variable
predicted membership of a dichotomous dependent variable. Specifically, in this
analysis, LR compared the odds of participants who had a reduction of severity on the
second behavior given a reduction of severity on the first behavior compared to
participants who only had a reduction of severity on the second behavior and did not have
a reduction of severity on the first behavior from baseline to 24-month follow-up by
treatment condition. Therefore, results show the odds of participants who had a reduction
of severity on both behaviors compared to the odds of reduction of severity only on the
second behavior from baseline to 24-month by treatment condition.
Drawing from harm reduction theory and the literature on decisional balance for
separate behaviors, analyses defined reduction in severity in the following ways. For
smoking, reduction in severity was defined as a 30% reduction in smoking from baseline
to 24-month follow-up. For diet, reduction in severity was defined as a .3 SD increase on
the total behavior score at 24-month follow-up. For sun protection, reduction in severity
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was defined as a .3 SD increase on the total behavior score at 24-month follow-up. The
.3 SD increase on the diet and sun protection behavior measures is based on each measure
having higher total scores correlated with reduced health risk on that specific behavior.
The independent and dependent variables were analyzed by the same three
behavior pairs: 1) sun protection and diet, 2) smoking and diet, 3) smoking and sun
protection at baseline and at 24-month follow-up. Specifically, each behavior within the
pair was dichotomized into participants who did and did not meet reduction in severity
criteria from baseline to 24-month follow-up. Participants who did not meet criteria were
categorized with a 0 (i.e., ‘did not meet reduction in severity criteria’) and participants
who did meet reduction in severity criteria from baseline to 24-month were categorized
with a 1 (i.e., ‘did meet reduction in severity criteria’). All analyses were run separately
for the control, treatment, and total conditions.
After running each LR, a series of crosstabulations was conducted to reveal the
specific number of participants who met criteria for both behaviors in the behavior pair
by treatment condition compared to the participants who met the reduction on severity
criteria on the second behavior but did not meet reduction on severity criteria on the first
behavior. Thereafter, conditional confidence intervals were then calculated to reveal the
specific proportion that number of participants represents for each behavior pair by
treatment condition. As such, the reported proportions reflect the number of participants
who met reduction in severity criteria on both behaviors compared to participants who
only met the reduction of severity criteria on the second behavior but not on the first
behavior for each behavior pair by treatment condition. Therefore, results allow for a
direct comparison between treatment and control conditions.
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H4) Participants who increase their Pros and Cons by a defined amount on one
behavior will do the same for a second behavior, with more co-progression observed in
the treatment than the control group.
Analysis 4: A series of LR analyses evaluated the likelihood of whether increasing
Pros by one standard deviation and decreasing Cons one half standard deviation on one
behavior increased the likelihood of doing the same on a second behavior, and assessed
any differences between the treatment and control groups.
LR was performed to see how well one categorical, independent variable
predicted membership of a dichotomous dependent variable. Specifically, in this
analysis, LR compared the odds of participants who increased their Pros by one standard
deviation and reduced their Cons by a half standard deviation on the second behavior
having met the same criteria on the first behavior compared to participants who only
increased their Pros by one standard deviation and reduced their Cons by a half standard
deviation on the second behavior not having met the same criteria on the first behavior
from baseline to 24-month follow-up by treatment condition.
Similar to previous analyses, the independent and dependent variables were
analyzed by behavior pairs: 1) sun protection and diet, 2) smoking and diet, 3) smoking
and sun protection. In these analyses, the independent variables (i.e., the first behavior of
the pair) and the dependent variables (i.e., the second behavior of the pair) were both
categorized as either increasing Pros one standard deviation and reducing Cons by a half
standard deviation from baseline to 24-month follow-up on that behavior, either yes or
no. Participants who did not meet this criterion were categorized with a 0 (i.e., “did not
met strong and weak principles”) and participants who met this criterion were categorized
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with a 1 (i.e., “met strong and weak principles”). Given the stringent criteria, the strong
and weak principles analyses were not able to be completed as planned because there
were zero participants who met criteria for behavior pairs across each condition.
Also, because the original strong and weak principles were based on the
transitions from participants progressing from PC-A for separate behaviors, and this
research examined all Stages of Change (SOC) movements including PC-A, C-A, and
PR-A, a revised approach using a .4 SD Pros increase for each behavior in the behavior
pair was used to better understand how decisional balance relates to multiple health
behavior change. Therefore, in this analysis, LR compared the odds of participants who
increased their Pros by .4 SD on the second behavior given participants increased their
Pros .4 SD on the first behavior compared to participants who only increased their Pros .4
SD on the second behavior, not having increased their Pros by .4 SD on the first
behavior, from baseline to 24-month follow-up by treatment condition.
To complete the revised analyses, the same three behavior pairs were examined
using the same independent and dependent variables: 1) sun protection and diet, 2)
smoking and diet, 3) smoking and sun protection at baseline and at 24-month follow-up.
Specifically, the dataset was categorized to identify those participants who made a .4 SD
increase on Pros on the second behavior given a .4 SD increase on Pros on the first
behavior, either yes or no (i.e., 1= “met .4 SD Pros increase criteria” and 0= “did not
meet .4 SD Pros increase criteria”), and participants who only met the .4 SD increase on
Pros on the second behavior given no .4 SD increase on Pros on the first behavior, either
yes or no (i.e., 1= “met .4 SD Pros increase criteria” and 0= “did not meet .4 SD Pros
increase criteria”), from baseline to 24-month follow-up by treatment condition.
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After running each LR, a series of crosstabulations was conducted to reveal the
specific number of participants who met the .4 SD increase on Pros criteria for both
behaviors in the behavior pair compared to the participants who met the .4 SD increase
on Pros criteria only for the second behavior but not for the first behavior. As such, the
reported proportions represents the number of participants who met the .4 SD increase on
Pros criteria for both behaviors compared to the number of participants who met the .4
SD increase on Pros criteria only on the second behavior. Conditional confidence
intervals were then calculated to reveal the specific proportion that number of participants
represents for each behavior pair for each treatment condition. Therefore, results allow
for a direct comparison between treatment and control conditions.
H5) As an exploratory approach, it is expected that participants who move to
Action/Maintenance on only one behavior will also show smaller signs of success as
defined by: a) making stage progress on a second behavior, b) decreasing severity on a
second behavior; and c) increasing their Pros and decreasing their Cons on a second
behavior. It is also expected that these changes will be observed in the treatment group
more than in the control group.
Analysis 5: Descriptive statistics and crosstabulations evaluated whether
participants who moved to criteria (i.e., Action/Maintenance) on only one behavior also
made smaller changes (described above) on other behaviors. Upon a thorough review of
the data, this hypothesis was answered by previous analyses as outlined in the results and
discussion sections.
H6) Paired action and co-progression are not expected to vary by race or gender.
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Analysis 6: The series of LR analyzed in H2 through H4 were repeated to assess
any differences in paired action and co-progression rates between race and gender. The
same categorization outlined in the previous analyses was repeated with the dataset
having first been filtered for race (i.e., 0=Whites and 1=Non-Whites) and then re-run
having been filtered for gender (i.e., 0=females and 1=males). Therefore, these analyses
revealed any differences between race and gender on the odds of meeting criteria (i.e.,
defined differently for each hypothesis) on the second behavior having met criteria on the
first behavior compared to the odds of meeting criteria on the second behavior and not
having met criteria on the first behavior from baseline to 24-month follow-up for each
behavior pair by treatment condition.
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CHAPTER 4
FINDINGS
Sample:
The participants (N=9,461) were predominantly White (93.8%), middle-aged (X=
43.9 years-old, SD=10.74), female (65.4%), and recruited solely from a Northeastern
state. Table 2 provides additional detail on the three referral sources (i.e., parent, patient,
and worksite) as well as the gender, marital status, and ethnic composition for the control,
treatment, and total sample.
Hypotheses:
H1) Participants in Contemplation (C) or Preparation (PR) at baseline for two
behaviors will be more likely to move to criteria (Action/Maintenance) on both behaviors
at final follow-up (i.e., paired action) than participants who are in Precontemplation (PC)
at baseline for both behaviors.
Table 3 provides the participants who moved to criteria and the paired action odds
ratios of progressing to A/M on both behaviors at 24-month follow-up (i.e., the dependent
variable) given the participant was either in PC or C/PR for both behaviors at baseline
(i.e., the independent variable).
Sun Protection and Diet
Entire Sample: Results were significant, OR=5.40 [2.68, 10.90], p <.001,
indicating that participants in Contemplation or Preparation (i.e., C/PR) for sun protection
and diet at baseline were almost five and a half times more likely to progress to
Action/Maintenance (i.e., A/M) on both behaviors at 24-month follow-up than
participants who were in Precontemplation (i.e., PC) for both behaviors at baseline.
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Treatment Group: Results were significant, OR=4.53 [1.89, 10.85], p <.001,
indicating that participants who were in C/PR for sun protection and diet at baseline were
over four and a half times more likely to move to A/M on sun protection and diet than
participants who were in PC for both behaviors at baseline.
Control Group: Results were significant, OR=6.97 [2.11, 23.04], p <.001,
indicating that participants who were in C/PR for both behaviors were almost seven times
more likely to move to A/M on both sun protection and diet than participants who were in
PC for both behaviors at baseline.
Smoking and Diet
Entire Sample: Results were not significant, OR=2.22, [0.79, 6.27], p <.132,
indicating that although participants in C/PR for both smoking and diet at baseline were
more than two times more likely to progress to A/M on smoking and diet at 24-month
follow-up than participants who were in PC for both behaviors at baseline, the odds ratio
between the groups was not reliably different.
Treatment Group. Results were not significant, OR=2.22 [0.45, 10.98], p <.330,
indicating that although participants who were in C/PR for smoking and diet at baseline
were more than two times more likely to progress to A/M on both behaviors at 24-month
follow-up than participants who were in PC for both behaviors at baseline, the difference
between the groups was not significantly different.
Control Group. Results were not significant, OR=2.14 [0.54, 8.44], p <.278,
indicating that although participants who were in C/PR for both behaviors were more
than two times more likely to progress to A/M on smoking and diet at 24-month follow-
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up than participants who were in PC for both behaviors at baseline, the odds ratio
between participants who were in C/PR compared to PC was not significant.
Smoking and Sun Protection
Entire Sample: Results were significant, OR=4.38 [1.00, 19.03], p <.049,
indicating that participants who were in C/PR for smoking and sun protection at baseline
were more than four times more likely to progress to A/M on both behaviors at 24-month
follow-up than participants who were in PC for both behaviors at baseline.
Treatment Group. Odds ratios were not able to be calculated between the groups
because zero participants who were in PC for both behaviors at baseline progressed to
A/M on both behaviors at 24-month follow-up. Therefore, although 14 participants who
were in C/PR for both behaviors at baseline did progress to A/M on both behaviors at 24month follow-up, odds ratios could not be calculated because zero participants met
criteria in the comparison group.
Control Group. Results were not significant, OR=1.20 [0.23, 6.30], p <.831,
indicating that although participants who were in C/PR for smoking and sun protection
were more likely to progress to A/M on both behaviors at 24-month follow-up, the
difference between the comparison groups was not significant.
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#

Table 2. Demographics and descriptive statistics for control, treatment, and total sample, baseline-24 months .

Study

Gender

Marital Status

Ethnicity

Treatment

Total

(N=4800)

(N=4661)

(N=9461)

Parent

N
1238

%
25.8%

N
1197

%
25.7%

N
2435

%
25.7%

Patient

2620

54.6%

2550

54.7%

5170

54.6%

Worksite

942

19.6%

914

19.6%

1856

19.6%

Male

1596

34.6%

1545

34.6%

3141

34.6%

Female

3017

65.4%

2921

65.4%

5938

65.4%

Married

3265

70.9%

3176

71.3%

6441

71.1%

Not Married, living w/Partner

163

3.5%

157

3.5%

320

3.5%

Not Married

460

10.0%

462

10.4%

922

10.2%

Separated

89

1.9%

90

2.0%

179

2.0%

Divorced

480

10.4%

452

10.1%

932

10.3%

Widowed

149

3.2%

119

2.7%

268

3.0%

American Indian, Alaskan

21

0.5%

20

0.4%

41

0.5%

Asian, Pacific Islander

40

0.9%

34

0.8%

74

0.8%

Black, Non-Hispanic

74

1.6%

82

1.8%

156

1.7%

Hispanic

46

1.0%

45

1.0%

91

1.0%

White

4319

93.7%

4184

93.8%

8503

93.7%

Other/Combination

109

2.4%

96

2.2%

205

2.3%

Mean

SD

N

Mean

SD

Mean

SD

4589

43.74

Age
#

Control

44.07

Recruited in 1999 in the United States.
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10.7

10.7

43.90

10.7

Table 3. Comparison of paired action rates among participants who were either in Precontemplation (PC)
or in Contemplation/Preparation (C/PR) for both behaviors at baseline and were in
Action/Maintenance (A/M) for both behaviors at 24-month follow-up.

Control
Proportion (n/total N)
Confidence Interval

Treatment
Proportion (n/total N)
Confidence Interval

Total
Proportion (n/total N)
Confidence Interval

.01 (3/401)
[.00, .02]

.02 (6/261)
[.00, .04]

.01 (9/662)
[.00, .02]

.05 (29/581)
[.03, .07]

.10 (40/415)
[.07, .13]

.07 (69/996)
[.05, .09]

6.97*** (2.11, 23.04)

4.53*** (1.89, 10.85)

5.40*** (2.68, 10.90)

Paired Action: Participants who
progressed to A/M on smoking and
diet given PC at baseline
Paired Action: Participants who
progressed to A/M on smoking and
diet given C/PR at baseline

.02 (3/134)
[.00, .04]

.03 (2/71)
[.00, .07]

.02 (5/205)
[.00, .04]

.05 (7/150)
[.02, .08]

.06 (7/116)
[.02, .10]

.07 (14/266)
[.04, .10]

Paired action odds ratioa
Smoking & Sun Protection

2.14 (0.54, 8.44)

2.22 (0.45, 10.98)

2.22 (0.79, 6.27)

.02 (2/95)
[.00, .05]

.00 (0/60)
[.00, .00]

.01 (2/155)
[.00, .02]

.03 (5/199)
[.00, .05]

.09 (14/152)
[.05, .14]

.05 (19/351)
[.03, .08]

1.20 (0.23, 6.30)

0.00 (0.00, 0.00)

4.38** (1.00, 19.03)

Sun Protection & Diet
Paired Action: Participants who
progressed to A/M on sun protection
and diet given PC at baseline
Paired Action: Participants who
progressed to A/M on sun protection
and diet given C/PR at baseline

Paired action odds ratioa
Smoking & Diet

Paired Action: Participants who
progressed to A/M on smoking and
sun protection given PC at baseline
Paired Action: Participants who
progressed to A/M on smoking and
sun protection given C/PR at baseline

Paired action odds ratioa
**

p< .05. *** p< .001;
Percentages in control and treatment conditions reflect proportion within that condition, not the total;
#
Recruited in 1999 in the United States.
a
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H2) Participants who make stage progress (i.e., progress at least one stage) on one
behavior will also make stage progress on a second behavior, with more co-progression
observed in the treatment than the control group.
Table 4 provides the participants who progressed to criteria and the coprogression odds ratios of making stage progress on a second behavior given stage
progress on the first behavior compared to the odds of participants who made stage
progress on the second behavior not having made stage progress on the first behavior
from baseline to 24-month follow-up for each behavior pair and treatment condition.
Sun Protection and Diet
Entire Sample: Results were significant, OR= 1.46 [1.25, 1.70], p < .000,
indicating that participants who made stage progress on diet given stage progress on sun
protection were almost one and a half times more likely to make stage progress on diet
compared to participants who only made stage progress on diet.
Treatment Group: Results were significant, OR= 1.85 [1.48, 2.32], p < .000,
indicating that participants who made stage progress on diet given stage progress on sun
protection were almost twice as likely to make stage progress on diet compared to
participants who only made stage progress on diet.
Control Group: Results were not significant, OR= 1.10 [0.88, 1.37], p < .414,
indicating that although participants who made stage progress on diet given stage
progress on sun protection were slightly more likely to make stage progress on diet
compared to participants who only made stage progress on diet, the difference between
the comparison groups was not significant.
Smoking and Diet
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Entire Sample: Results were significant, OR= 1.40 [1.05, 1.86], p < .021,
indicating that participants who made stage progress on diet given stage progress on
smoking were almost one and a half times more likely to make stage progress on diet
compared to participants who only made stage progress on diet.
Treatment Group: Results were not significant, OR= 1.17 [0.76, 1.80], p < .484,
indicating that although participants who made stage progress on diet given stage
progress were slightly more likely to make stage progress on diet compared to
participants who only made stage progress on diet, the difference between the groups was
not reliable.
Control Group: Results were significant, OR= 1.56 [1.07, 2.28], p < .021,
indicating that participants who made stage progress on diet given stage progress on
smoking were more than one and a half times more likely to make stage progress on diet
compared to participants who only made stage progress on diet.
Smoking and Sun Protection
Entire Sample: Results were not significant, OR= 1.16 [0.87, 1.55], p < .305,
indicating that although participants who made stage progress on sun protection given
stage progress on smoking were slightly more likely to make stage progress on sun
protection compared to participants who only made stage progress on sun protection, the
difference between the comparison groups was not significant.
Treatment Group: Results were not significant, OR= 1.22 [0.81, 1.85], p < .358,
indicating that although participants who made stage progress on sun protection given
stage progress on smoking were almost one and a quarter times more likely to make
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progress on sun protection compared to participants who only made stage progress on sun
protection, the difference between the comparison groups was not significant.
Control Group: Results were not significant, OR= 1.03 [0.70, 1.55], p < .907,
indicating that although participants who made stage progress on sun protection given
stage progress on smoking were slightly more likely to make stage progress on sun
protection compared to participants who only made stage progress on sun protection, the
difference between the comparison groups was not significant.

39

Table 4. Stage progress co-progression rates from baseline to 24-month follow-up by treatment condition#;
Percentages in control and treatment conditions reflect proportion within that condition, not total.

Control
Proportion (n/total N)
Confidence Interval

Treatment
Proportion (n/total N)
Confidence Interval

Total
Proportion (n/total N)
Confidence Interval

.34 (167/498)
[.29, .38]

.48 (256/536)
[.33, .57]

.41 (423/1034)
[.38, .44]

.32 (399/1266)
[.29, .34]

.33 (256/774)
[.30, .36]

.32 (655/2040)
[.30, .34]

1.10 (0.88, 1.37)

1.85***(1.48, 2.32)

1.46***(1.25, 1.70)

.37 (69/188)
[.30, .44]

.39 (57/148)
[.31, .46]

.38 (126/336)
[.32, .43]

.27 (95/351)
[.22, .32]

.35 (74/212)
[.28, .41]

.30 (169/563)
[.26, .34]

1.17 (0.76, 1.80)

1.40** (1.05, 1.86)

.27 (47/175)
[.20, .33]

.39 (65/167)
[.32, .46]

.33 (112/342)
[.23, .43]

.26 (91/345)
[.22, .31]

.34 (76/221)
[.28, .41]

.30 (167/586)
[.26, .34]

1.03 (0.70, 1.55)

1.22 (0.81, 1.85)

1.16 (0.87, 1.55)

Sun Protection & Diet
Participants who made stage progress
on diet given stage progress on sun
protection
Participants who made stage progress
on diet given no stage progress on sun
protection

Co-progression odds ratioa
Smoking & Diet
Participants who made stage progress
on diet given stage progress on
smoking
Participants who made stage progress
on diet given no stage progress on
smoking

Co-progression odds ratioa
Smoking & Sun Protection
Participants who made stage progress
on sun protection given stage progress
on smoking
Participants who made stage progress
on sun protection given no stage
progress on smoking

Co-progression odds ratioa

1.56**(1.07, 2.28)

**

p< .05. *** p< .001;
Co-progression rates of stage progress on second behavior given stage progress on the first behavior;
#
Recruited in 1999 in the United States.
a

40

H3) Participants who decrease their severity by a defined amount on one behavior
will also decrease their severity on a second behavior, with more co-progression observed
in the treatment than the control group.
Table 5 provides the participants who progressed to criteria and the coprogression odds ratios of reduction on severity on a second behavior given reduction on
severity on the first behavior compared to the odds of participants who had a reduction on
severity on the second behavior not having reduced severity on the first behavior from
baseline to 24-month follow-up for each behavior pair by treatment condition.
Specifically, reduction on severity was defined as a 30% reduction in the number of
cigarettes smoked from baseline to 24-month follow-up and at least a .3 SD increase on
the diet behavior total score for diet and a .3 SD increase on the sun exposure behavior
total score for unprotected sun exposure, both from baseline to 24-month follow-up.
Sun Protection and Diet
Entire Sample: Results were significant, OR= 1.26 [1.09, 1.46], p < .002,
indicating that participants who had a reduction on severity on diet given a reduction on
severity on sun protection were more than one and a quarter times more likely to reduce
severity on diet compared to participants who only reduced severity on diet alone.
Treatment Group: Results were significant, OR= 1.34 [1.08, 1.67], p < .008,
indicating that participants who reduced severity on diet given reduced severity on sun
protection were more than one and a third times more likely to reduce severity on diet
compared to participants who only reduced severity on diet alone.
Control Group: Results were not significant, OR= 1.11 [0.92, 1.35], p < .280,
indicating that although participants were slightly more likely to reduce severity on diet
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given reduced severity on sun protection compared to participants who reduced severity
on diet alone, the difference between the comparison groups was not reliable.
Smoking and Diet
Entire Sample: Results were significant, OR= 1.40 [1.01, 1.77], p < .039,
indicating that participants who reduced severity on diet given reduced severity on
smoking were more than one and a third times more likely to reduce severity on diet
compared to participants who only reduced severity on diet alone.
Treatment Group: Results were not significant, OR= 0.94 [0.62, 1.44], p < .787,
indicating that although participants had a slightly lower likelihood of a reduction on
severity diet given a reduction of severity on smoking compared to participants who had
a reduction on diet alone, the difference between the comparison groups was not reliable.
Control Group: Results were significant, OR= 1.69 [1.17, 2.45], p < .005,
indicating that participants who reduced severity on diet given reduced severity on
smoking were more than one and a half times more likely to reduce severity on diet
compared to participants who only reduced severity on diet alone.
Smoking and Sun Protection
Entire Sample: Results were not significant, OR= 1.16 [0.88, 1.52], p < .288,
indicating that although participants who reduced severity on sun protection given
reduced severity on smoking were slightly more likely to reduce severity on sun
protection compared to participants who only reduced severity on sun protection alone,
the difference between the groups was not reliable.
Treatment Group: Results were not significant, OR= 1.35 [0.90, 2.05], p < .152,
indicating that although participants who reduced severity on sun protection given
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reduced severity on smoking were more likely to reduce severity on sun protection
compared to participants who only reduced severity on sun protection alone, the
difference between this group was not reliably different.
Control Group: Results were not significant, OR= 1.00 [0.70, 1.44], p < .987,
indicating that although participants who reduced severity on sun protection given
reduced severity on smoking were just as likely to reduce harm on sun protection as
participants who only reduced harm on sun protection alone, the difference between the
comparison groups was not reliable.
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Table 5.Reduction on severity co-progression rates baseline to 24-month follow-up by treatment condition#;
30% reduction in smoking and a .3 SD reduction in severity on diet and sun total behavior scores;
Percentages in control and treatment conditions reflect proportion within that condition, not total.

Control
Proportion (n/total N)
Confidence Interval

Treatment
Proportion (n/total N)
Confidence Interval

Total
Proportion (n/total N)
Confidence Interval

.38 (307/814)
[.35,.41]

.52 (379/733)
[.48,.56]

.44 (686/1547)
[.42,.46]

.35 (339/962)
[.32,.38]

.44 (262/590)
[.40,.48]

.39 (601/1552)
[.37,.41]

Sun Protection & Diet
Participants who reduced severity on
diet given reduced severity on sun
protection
Participants who reduced severity on
diet given no reduced severity on sun
protection

Co-progression odds ratioa
Smoking & Diet
Participants who reduced severity on
diet given reduced severity on
smoking
Participants who reduced severity on
diet given no reduced severity on
smoking

Co-progression odds ratioa
Smoking & Sun Protection
Participants who reduced severity on
sun protection given reduced severity
on smoking
Participants who reduced severity on
sun protection given no reduced
severity on smoking

Co-progression odds ratioa

1.11 (0.92, 1.35)

1.34** (1.08, 1.67)

1.26** (1.09, 1.46)

.43 (75/176)
[.36,.50]

.44 (60/138)
[.36,.52]

.43 (135/314)
[.38,.48]

.31 (116/380)
[.26,.36]

.45 (106/236)
[.39,.51]

.36 (222/616)
[.32,.40]

1.69** (1.17, 2.45)

0.94 (0.62, 1.44)

1.40** (1.01, 1.77)

.47 (80/170)
[.39,.55]

.60 (84/141)
[.52,.68]

.53 (164/311)
[.47,.59]

.47 (179/381)
[.42,.52]

.52 (136/261)
[.46,.58]

.49 (315/642)
[.45,.53]

1.00 (0.70, 1.44)

1.35 (0.90, 2.05)

1.16 (0.88, 1.52)

**

p< .05. *** p< .001;
Odds of stage progress on second behavior given stage progress on the first behavior;
#
Recruited in 1999 in the United States.
a
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H4) Participants who increase their Pros and Cons by a defined amount on one
behavior will do the same for a second behavior, with more co-progression observed in
the treatment than the control group.
Table 6 provides the participants and co-progression odds ratios for participants
who made a .4 SD increase in Pros on the second behavior given a .4 SD increase in Pros
on the first behavior compared to participants who only made a .4 SD increase on the
second behavior in the behavior pair from baseline to 24-month follow-up by treatment
condition.
Sun Protection and Diet
Entire Sample: Results were significant, OR= 1.38 [1.14, 1.67], p < .001,
indicating that participants who increased their Pros by .4 SD on diet given a .4 SD
increase of their Pros on sun protection were more than one and a third times more likely
to increase their Pros .4 SD on diet compared to participants who only increased their
Pros .4 SD on diet alone.
Treatment Group: Results were not significant, OR= 1.06 [0.79, 1.43], p < .693,
indicating that although participants who increased their Pros on diet by .4 SD given they
also increased their Pros .4 SD on sun protection were slightly more likely to increase
their Pros .4 SD on diet compared to participants who only increased their Pros by .4 SD
on diet, the difference between the comparison groups was not reliable.
Control Group: Results were significant, OR= 1.71 [1.33, 2.19], p < .000,
indicating that participants who increased their Pros .4 SD on diet given they increased
their Pros .4 SD on sun protection were almost two times as likely to increase their Pros
.4 SD on diet compared to participants who increased their Pros .4 SD on diet alone.
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Smoking and Diet
Entire Sample: Results were not significant, OR= 1.38 [0.97, 1.97], p < .072,
indicating that although participants who increased their Pros .4 SD from baseline to 24month follow-up on diet given they increased their Pros .4 SD on smoking were almost
one and a half times more likely to increase their Pros by .4 SD on diet compared to
participants who increased their Pros on diet alone, the difference between the
comparison groups was not reliable.
Treatment Group: Results were significant, OR=1. 75 [0.99, 3.09], p < .052,
indicating that smokers who increased their Pros .4 SD on diet given a .4 SD increase on
Pros on smoking had a one and three quarter increased likelihood of increasing their Pros
.4 SD on diet compared to smokers who only increased their Pros by .4 SD on diet alone.
Control Group: Results were not significant, OR= 1.19, [0.76, 1.87], p < .448,
indicating that although participants who increased their Pros .4 SD on diet given a .4 SD
increased Pros on smoking were almost one and a quarter times more likely to increase
their Pros on diet by .4 SD compared to smokers who only increased their Pros by .4 SD
on diet, the difference between the comparison groups was not reliable.
Smoking and Sun Protection
Entire Sample: Results were significant, OR= 1.48 [1.07, 2.05], p < .019,
indicating that participants who increased their Pros .4 SD on sun protection given a .4
SD increased Pros on smoking were almost one and a half times more likely to increase
their Pros .4 SD on sun protection compared to smokers who only increased their Pros .4
SD on sun protection alone, the difference between the comparison groups was not
reliable.
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Treatment Group: Results were not significant, OR= 1.07 [0.64, 1.78], p < .799,
indicating that although participants who increased their Pros .4 SD on sun protection
given a .4 SD increased Pros on smoking were slightly more likely to increase their Pros
.4 SD on sun protection compared to participants who increased their Pros by .4 SD on
sun protection alone, the difference between the comparison groups was not reliable.
Control Group: Results were significant, OR= 1.87 [1.22, 2.87], p < .004,
indicating that smokers who increased their Pros .4 SD on sun protection given a .4 SD
increased Pros on smoking were almost two times more likely to increase their Pros by .4
SD on sun protection compared to smokers who increased their Pros by .4 SD on sun
protection alone.
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Table 6. .4 SD Pros increase on both behaviors from baseline to 24-mo. follow-up by treatment condition#;
Percentages in control and treatment conditions reflect proportion within that condition, not total;
Control
Proportion (n/total N)
Confidence Interval

Treatment
Proportion (n/total N)
Confidence Interval

Total
Proportion (n/total N)
Confidence Interval

.29 (124/425)
[.25,.33]

.21 (79/384)
[.17,.25]

.25 (203/809)
[.22,.28]

.19 (249/1281)
[.17,.21]

.20 (170/867)
[.17,.23]

.20 (419/2148)
[.18,.22]

1.71*** (1.33, 2.19)

1.06 (0.79, 1.43)

1.38*** (1.14, 1.67)

.24 (35/145)
[.20,.28]

.28 (23/82)
[.18,.38]

.26 (58/227)
[.20,.32]

.21 (82/389)
[.17,.25]

.18 (51/280)
[.13,.23]

.20 (133/669)
[.17,.23]

1.19 (0.76, 1.87)

1.75** (0.99, 3.09)

1.38 (0.97, 1.97)

.35 (46/130)
[.27,.43]

.28 (27/96)
[.19,.37]

.32 (73/226)
[.26,.38]

.23 (95/420)
[.19,.27]

.25 (82/306)
[.212,.32]

.24 (177/726)
[.21,.27]

1.87** (1.22, 2.87)

1.07 (0.64, 1.78)

1.48** (1.07, 2.05)

Sun Protection & Diet
Participants with .4 SD Pros increase
on diet given a .4 SD Pros increase
on sun protection
Participants with .4 SD Pros increase
on diet given no .4 SD Pros increase
on sun protection

Co-progression odds ratioa
Smoking & Diet
Participants with .4 SD Pros increase
on diet given a .4 SD Pros increase
on smoking
Participants with .4 SD Pros increase
on diet given no .4 SD Pros increase
on smoking

Co-progression odds ratioa
Smoking & Sun Protection
Participants with .4 SD Pros increase
on sun protection given a .4 SD Pros
increase on smoking
Participants with .4 SD Pros increase
on sun protection given no .4 SD
Pros increase on smoking

Co-progression odds ratioa
**

p< .05. *** p< .001;
Odds of increasing Pros by .4 SD on second behavior given increased Pros by .4 SD on the first behavior;
#
Recruited in 1999 in the United States.
a
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H5) As an exploratory approach, it is expected that participants who move to
Action/Maintenance on only one behavior will also show smaller signs of success as
defined by: a) making stage progress on a second behavior, b) decreasing severity on a
second behavior; and c) increasing their Pros and decreasing their Cons on a second
behavior. It is also expected that these changes will be observed in the treatment group
more than in the control group.
For part “a” of hypothesis 5, a series of crosstabulations explored whether
participants who progressed to A/M on the first behavior of the behavior pair at 24-month
follow-up made stage progress on the second behavior at 24-month follow-up. After
completing the crosstabulations, it was clear that this part of hypothesis 5 was answered
in the first and second set of logistic regressions. Specifically, the first set of logistic
regression analyses calculated the odds ratios for participants in earlier (i.e., PC) versus
later (i.e., C/PR) stages of change (SOC) at baseline and whether they moved to A/M on
both behaviors at 24-month follow-up. The second set of logistic regression analyses
calculated the odds ratios of participants who made stage progress on either or both
behaviors in the behavior pair from baseline to 24-month follow-up, regardless of
baseline stage of change. That is, unlike the first set of logistic regressions, the second
set of analyses allowed participants to be in either PC, C, PR, or A for either or both of
the behaviors in the behavior pair and to progress one stage by 24-month follow-up.
After identifying those participants, analyses calculated the odds ratios between the
participants who made stage progress on the second behavior given stage progress on the
first behavior compared to the participants who only made stage progress on the second
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behavior from baseline to 24-month follow-up. Given the thorough and more stringent
criteria for these analyses, part “a” of this hypothesis was already answered.
For part “b” of hypothesis 5, a series of crosstabulations explored whether
participants who progressed to A/M on the first behavior of the behavior pair at 24-month
follow-up reduced severity on the second behavior at 24-month follow-up. Similar to the
initial set of planned analyses for hypothesis 3, there was insufficient sample size to
complete analyses as initially planned. Similar to part “a” of this hypothesis, this part of
hypothesis 5 was already answered by the logistic regressions performed for hypothesis
3. Specifically, the reduction in severity analyses (i.e., 30% reduction in smoking and a
.3 SD reduction in harm on diet and unprotected sun exposure) as presented in hypothesis
3 answered this part of the hypothesis.
For part “c” of hypothesis 5, a series of crosstabulations explored whether
participants who progressed to A/M on the first behavior of the behavior pair at 24-month
follow-up increased their Pros one standard deviation and reduced their Cons by a half
standard deviation on the second behavior at 24-month follow-up. Similar to the original
analyses for hypothesis 4, there was an insufficient sample size in order to conduct these
analyses as there was zero and at most three participants who met the strong and weak
principle criteria on the first behavior with even fewer participants who met the criteria
for the second behavior. Therefore, the revised analyses (i.e., .4 SD Pros increase) for
each behavior in the same three behavior pairs as presented in hypothesis 4 will be relied
upon to answer this part of hypothesis 5.
For the last part of hypothesis 5, expecting greater co-progression rates in
treatment versus control conditions, this will be evaluated in the discussion section as a
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general conclusion based on the overall results of this research. That is, the discussion
will consist of empirically supported conclusions based on the general and specific
findings of this research.
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H6) Paired action and co-progression are not expected to vary by race or gender.
Stage progress (i.e., H2) by race and gender
Table 7 presents the participants who progressed to criteria and the co-progression
odds ratios of making stage progress on the second behavior given stage progress on the
first behavior compared to the participants who made stage progress on the second
behavior not having made stage progress on the first behavior from baseline to 24-month
follow-up for Whites and Non-Whites.
Sun Protection and Diet
Results were significant for Whites, OR= 1.49 [1.27, 1.74], p < .001, indicating
that Whites were almost one and half times more likely to make stage progress on diet
given stage progress on sun protection compared to Whites who only made stage
progress on diet. However, results were not significant for Non-Whites, OR= 1.24 [0.59,
2.60], p < .578, indicating that although Non-Whites were slightly more likely to make
stage progress on diet given stage progress on sun protection compared to Non-Whites
who only made stage progress on diet alone, the difference between the Non-White
comparison groups was not reliable.
Smoking and Diet
Results were significant for Whites, OR= 1.41 [1.05, 1.89], p < .021, indicating
that Whites were almost one and a half times more likely to make stage progress on diet
given stage progress on smoking compared to Whites who only made stage progress on
diet. However, results were not significant for Non-Whites, OR= 1.11 [0.29, 4.31], p <
.879, indicating that although Non-Whites had a slightly higher likelihood of making
stage progress on diet given stage progress on smoking compared to Non-Whites who
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only made stage progress on diet, the difference between the Non-White comparison
groups was not reliable.
Smoking and Sun Protection
Results were not significant for Whites, OR= 1.16 [0.86, 1.56], p < .334, or NonWhites, OR= 1.26, [0.30, 5.30], p < .755, indicating that although both races were
slightly more likely to make stage progress on sun protection given stage progress on
smoking compared to their cohort who only made stage progress on sun protection, the
difference between the comparison groups within each race was not reliable.
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Table 7. Stage progress on second behavior given stage progress on the first behavior by race;
Co-progression odds ratios from baseline to 24 months#.
Whites
Proportion (n/total N)
Confidence Interval

Non-Whites
Proportion (n/total N)
Confidence Interval

Participants who made stage progress on diet
given stage progress on sun protection

.41 (405/980)
[.38, .44]

.35 (18/52)
[.22, .48]

Participants who made stage progress on diet
given no stage progress on sun protection

.32 (628/1953)
[.29, .34]

.30 (24/80)
[.20, .40]

Sun Protection & Diet

Co-progression odds ratioa
Smoking & Diet

1.49*** (1.27, 1.74)

1.24 (0.59, 2.60)

Participants who made stage progress on diet
given stage progress on smoking

.38 (120/320)
[.33, .43]

.36 (5/14)
[.11, .61]

Participants who made stage progress on diet
given no stage progress on smoking

.30 (159/533)
[.26, .34]

.33 (9/27)
[.15, .51]

1.41** (1.05, 1.89)

1.11 (0.29, 4.31)

Participants who made stage progress on sun
protection given stage progress on smoking

.33 (107/329)
[.28, .38]

.36 (4/11)
[.08, .64]

Participants who made stage progress on sun
protection given no stage progress on smoking

.29 (157/534)
[.25, .33]

.31 (10/32)
[.15, .47]

1.16 (0.86, 1.56)

1.26 (0.30, 5.30)

Co-progression odds ratioa
Smoking & Sun Protection

Co-progression odds ratioa
**

p< .05. *** p< .001.
Odds of stage progress on the second behavior given stage progress on the first behavior;
#
Recruited in 1999 in the United States.
a
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Table 8 presents the participants who progressed to criteria and the co-progression
odds ratios of making stage progress on the second behavior given stage progress on the
first behavior compared to making stage progress on the second behavior and not having
made stage progress on the first behavior from baseline to 24-month follow-up for males
and females.
Sun Protection and Diet
Results were significant for males, OR= 1.72 [1.35, 2.20], p <.001, and females,
OR= 1.30 [1.06, 1.59], p < .01 indicating that both sexes were more likely to make stage
progress on diet given stage progress on sun protection compared to their cohort on
making stage progress on diet alone; with males almost one and three quarters more
likely and females almost one and a half times more likely to make stage progress on diet
and sun protection compared to diet alone.
Smoking and Diet
Results were not significant for males, OR= 1.62 [.98, 2.69], p < .062, or females,
OR= 1.31, [0.92, 1.85], p < .132, indicating that although each sex was more likely to
make stage progress on diet given stage progress on smoking compared to making stage
progress on diet alone, the differences within the respective cohorts was not reliable.
Smoking and Sun Protection
Results were not significant for males, OR= 1.48 [0.88, 2.45], p < .133, or
females, OR= 1.05 [0.74, 1.51], p < .774, indicating that although both sexes had
increased likelihood of making stage progress on sun protection given stage progress on
smoking compared to their cohort who only made stage progress on sun protection alone,
the differences within the comparison groups was not reliable.
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Table 8. Stage progress on second behavior given stage progress on the first behavior by gender;
Co-progression odds ratios from baseline to 24 months#.
Males
Proportion (n/total N)
Confidence Interval

Females
Proportion (n/total N)
Confidence Interval

Participants who made stage progress on diet
given stage progress on sun protection

.40 (162/410)
[.35, .45]

.42 (261/623)
[.38, .46]

Participants who made stage progress on diet
given no stage progress on sun protection

.28 (248/902)
[.25, .31]

.36 (404/1132)
[.33, .39]

Sun Protection & Diet

1.72***(1.35, 2.20)

Co-progression odds ratioa
Smoking & Diet

1.30** (1.06, 1.59)

Participants who made stage progress on diet
given stage progress on smoking

.35 (40/114)
[.26, .44]

.39 (85/220)
[.33, .45]

Participants who made stage progress on diet
given no stage progress on smoking

.25 (47/188)
[.19, .31]

.33 (121/372)
[.28, .38]

1.62 (0.98, 2.69)

1.31 (0.92, 1.85)

Participants who made stage progress on sun
protection given stage progress on smoking

.30 (38/129)
[.22, .38]

.35 (73/211)
[.30, .38]

Participants who made stage progress on sun
protection given no stage progress on smoking

.22 (43/195)
[.16, .28]

.33 (124/371)
[.29, .41]

1.48 (0.88, 2.45)

1.05 (0.74, 1.51)

Co-progression odds ratioa
Smoking & Sun Protection

Co-progression odds ratioa
**

p< .05. *** p< .001.
Odds of stage progress on the second behavior given stage progress on the first behavior;
#
Recruited in 1999 in the United States.
a
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Reduction on severity (i.e., H3) by race and gender
Table 9 presents the participants who progressed to criteria and the co-progression
odds ratios for reduction on severity for each behavior pair from baseline to 24-month
follow-up by race. Specifically, Table 9 presents the participants and odds of reduction
on severity on the second behavior given reduction of severity on the first behavior
compared to the reduction of severity on the second behavior and no reduction on
severity on the first behavior from baseline to 24-month follow-up for Whites and NonWhites.
Sun Protection and Diet
Results were significant for Whites, OR= 1.28 [1.10, 1.48], p < .001, indicating
that Whites were more than one and a quarter times more likely to reduce severity on diet
given reduced severity on sun protection compared to Whites who only reduced severity
on diet alone. However, results were not significant for Non-Whites, OR= 1.02 [0.50,
2.05], p < .968, indicating that although Non-Whites were slightly more likely to reduce
severity on diet given reduced severity on sun protection compared to Non-Whites who
reduced severity on diet alone, the difference within the Non-White comparison groups
was not reliable.
Smoking and Diet
Results were significant for Whites, OR= 1.35 [1.02, 1.80], p < .037, indicating
that Whites were more than one and a third times more likely to reduce severity on diet
given reduced severity on smoking compared to Whites who reduced severity on diet
alone. In contrast, results were not significant for Non-Whites, OR= 1.59 [0.40, 6.38], p
< .515, indicating that although Non-Whites who reduced severity on diet given reduced
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severity on smoking were more than one and a half times more likely to reduce severity
on diet compared to Non-Whites who reduced severity on diet alone, the difference
within the comparison group was not reliable.
Smoking and Sun protection
Results were not significant for Whites, OR= 1.16 [0.88, 1.53], p < .287, or NonWhites, OR= 1.07 [0.28, 4.12], p < .920, indicating that although both groups were
slightly more likely to reduce severity on sun protection given reduced severity on
smoking compared to reduced severity on sun protection alone, the differences within
each comparison group was not reliable.
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Table 9. Reduction on severity on second behavior given reduction on severity on first behavior by race;
30% reduction in smoking and a .3 SD reduction in severity on diet and sun total behavior scores;
Co-progression odds ratios from baseline to 24 months#.
Whites
Proportion (n/total N)
Confidence Interval

Non-Whites
Proportion (n/total N)
Confidence Interval

Participants who reduced severity on diet given reduced
severity on unprotected sun exposure

.45 (658/1474)
[.42, .48]

.39 (26/67)
[.27, .51]

Participants who reduced severity on diet given no
reduced severity on unprotected sun exposure

.39 (575/1484)
[.37, .41]

.39 (25/65)
[.27, .51]

1.28***(1.10, 1.48)

1.02 (0.50, 2.05)

Participants who reduced severity on diet given reduced
severity on smoking

.44 (130/298)
[.38, .50]

.36 (5/14)
[.11, .61]

Participants who reduced severity on diet given no
reduced severity on smoking

.36 (212/583)
[.32, .40]

.26 (7/27)
[.09, .42]

1.35** (1.02, 1.80)

1.59 (0.40, 6.38)

Participants who reduced severity on unprotected sun
exposure given reduced severity on smoking

.53 (156/296)
[.47, .59]

.50 (6/12)
[.22, .78]

Participants who reduced severity on unprotected sun
exposure given reduced severity on smoking

.49 (298/609)
[.45, .53]

.48 (14/29)
[.30, .66]

1.16 (0.88, 1.53)

1.07 (0.28, 4.12)

Sun Protection & Diet

Co-progression odds ratioa
Smoking & Diet

Co-progression odds ratioa
Smoking & Sun Protection

Co-progression odds ratioa
**

p< .05. *** p< .001.
Odds of reduced severity on the second behavior given reduced severity on the first behavior;
#
Recruited in 1999 in the United States.

a
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Table 10 presents the participants who progressed to criteria and the coprogression odds ratios for reduction on severity for each behavior pair from baseline to
24-month follow-up by gender. Specifically, Table 10 presents the participants and odds
of reduction on severity on the second behavior given reduction on severity on the first
behavior compared to the reduction on severity on the second behavior and no reduction
on severity on the first behavior from baseline to 24-month follow-up for males and
females.
Sun Protection and Diet
Results were significant for males, OR= 1.24 [1.00, 1.55], p < .053, and females,
OR= 1.27 [1.05, 1.54], p < .013, indicating that both sexes were more likely to reduce
severity on diet given reduced severity on sun protection compared to reducing severity
on diet alone. Specifically, males were just under and females were just over one and a
quarter times more likely to reduce severity on diet and sun protection compared to
reducing severity on diet alone.
Smoking and Diet
Results were not significant for males, OR= 1.29 [0.80, 2.10], p < .303, indicating
that although males were more likely to reduce severity on diet given reduced severity on
smoking compared to males who reduced severity on diet alone, the difference within the
group was not reliable. In contrast, results were significant for females, OR= 1.41 [1.00,
1.99], p < .048, indicating that females were almost one and a half times more likely to
reduce severity on diet given reduced severity on smoking compared to females who
reduced severity on diet alone.
Smoking and Sun Protection
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Results were not significant for males, OR= 1.23 [0.78, 1.95], p < .371, or
females, OR= 1.11 [0.79, 1.56], p < .534, indicating that although each sex was more
likely to reduce severity on sun protection given reduced severity on smoking compared
to their cohort who reduced severity on sun protection alone, the differences within each
cohort were not reliable.
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Table 10. Reduction on severity on second behavior given reduction of severity on first behavior by gender;
30% reduction in smoking and a .3 SD reduction in severity on diet and sun total behavior scores;
Co-progression odds ratios from baseline to 24 months#.
Males
Proportion (n/total N)
Confidence Interval

Females
Proportion (n/total N)
Confidence Interval

Participants who reduced severity on diet given reduced
severity on unprotected sun exposure

.44 (286/649)
[.40, .48]

.45 (398/894)
[.42, .48]

Participants who reduced severity on diet given no
reduced severity on unprotected sun exposure

.39 (260/670)
[.35, .43]

.39 (340/879)
[.36, .42]

Sun Protection & Diet

1.24** (1.00, 1.55)

Co-progression odds ratioa
Smoking & Diet

1.27** (1.05, 1.54)

Participants who reduced severity on diet given reduced
severity on smoking

.41 (45/110)
[.32, .50]

.45 (90/202)
[.38, .52]

Participants who reduced severity on diet given no
reduced severity on smoking

.35 (70/200)
[.28, .42]

.36 (149/411)
[.31, .41]

1.29 (0.80, 2.10)

1.41** (1.00, 1.99)

Participants who reduced severity on unprotected sun
exposure given reduced severity on smoking

.50 (54/109)
[.40, .60]

.54 (108/199)
[.47, .61]

Participants who reduced severity on unprotected sun
exposure given reduced severity on smoking

.44 (102/230)
[.38, .50]

.52 (211/409)
[.47, .57]

1.23 (0.78, 1.95)

1.11 (0.79, 1.56)

Co-progression odds ratioa
Smoking & Sun Protection

Co-progression odds ratioa
**

p< .05. *** p< .001.
Odds of reduced severity on the second behavior given reduced severity on the first behavior;
#
Recruited in 1999 in the United States.
a
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Decisional Balance (DB) (i.e., H4) by race and gender
Table 11 presents the participants who progressed to criteria and the coprogression odds ratios for participants who increased their Pros .4 SD on the second
behavior given a .4 SD increase on Pros on the first behavior compared to participants
who increased their Pros .4 SD on the second behavior but did not increase their Pros .4
SD on the first behavior from baseline to 24-month follow-up for Whites and NonWhites.
Sun Protection and Diet
Results were significant for Whites, OR= 1.34 [1.10, 1.63], p < .004, indicating
that Whites were more than one and a third times more likely to increase their Pros on
diet by .4 SD given a .4 SD increase on sun protection compared to Whites who only
increased their Pros .4 SD on diet alone. In contrast, results were not significant for NonWhites, OR= 1.83 [0.85, 3.96], p < .125, indicating that although Non-Whites were
almost two times more likely to increase their Pros .4 SD on diet given a .4 SD on sun
protection compared to Non-Whites who increased their Pros .4 SD on diet alone, the
difference within the comparison groups was not reliable.
Smoking and Diet
Results were not significant for Whites, OR= 1.24 [0.86, 1.81], p < .249,
indicating that although Whites were slightly more likely to increase Pros .4 SD on diet
given a .4 SD increase on Pros on smoking compared to Whites who made a .4 SD
increase on diet alone, the difference within this group was not reliable. In contrast,
results were significant for Non-Whites, OR= 6.13 [1.46, 25.72], p < .013, indicating that
Non-Whites were over six times more likely to increase their Pros .4 SD on diet given a

63

.4 SD increase on Pros on smoking compared to Non-Whites who increased their Pros .4
SD on diet alone.
Smoking and Sun Protection
Results were significant for Whites, OR= 1.47 [1.05, 2.06], p < .025, indicating
that Whites were almost one and half times more likely to increase their Pros .4 SD on
sun protection given a .4 SD increase on Pros on smoking compared to Whites who only
increased their Pros .4 SD on sun protection alone. In contrast, results were not
significant for Non-Whites, OR= 1.43 [0.37, 5.55], p < .606, indicating that although
Non-Whites were almost one and a half times more likely to increase Pros .4 SD on sun
protection given a .4 SD increased Pros on smoking compared to Non-Whites who
increased their Pros by .4 SD on sun protection alone, the difference within Non-Whites
was not reliable.
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Table 11. .4 SD Pros increase on second behavior given .4 SD Pros increase on first behavior by race;
Co-progression odds ratios from baseline to 24 months#.
Whites
Proportion (n/total N)
Confidence Interval

Non-Whites
Proportion (n/total N)
Confidence Interval

Participants who increased Pros .4 SD on diet given
a .4 SD increase on Pros for sun protection

.24 (184/759)
[.18, .30]

.38 (18/48)
[.24, .51]

Participants who increased Pros .4 SD on diet given
no .4 SD increase on Pros for sun protection

.19 (398/2063)
[.18, .21]

.25 (20/81)
[.15, .34]

1.34** (1.10, 1.63)

1.83 (0.85, 3.96)

Participants who increased Pros .4 SD on diet given
a .4 SD increase on Pros for smoking

.24 (50/212)
[.18, .29]

.57 (8/14)
[.31, .83]

Participants who increased Pros .4 SD on diet given
no .4 SD increase on Pros for smoking

.20 (127/639)
[.17, .23]

.18 (5/28)
[.04, .32]

1.24 (0.86, 1.81)

6.13** (1.46, 25.72)

.32 (68/213)
[.26, .38]

.42 (5/12)
[.14, .70]

.24 (166/687)
[.21, .27]

.33 (11/33)
[.17, .49]

1.47 (1.05, 2.06)

1.43 (0.37, 5.55)

Sun Protection & Diet

a

Co-progression odds ratio
Smoking & Diet

Co-progression odds ratioa
Smoking & Sun Protection
Participants who increased Pros .4 SD on sun
protection given a .4 SD increase on Pros for
smoking
Participants who increased Pros .4 SD on sun
protection given no .4 SD increase on Pros on
smoking

Co-progression odds ratioa
**

p< .05. *** p< .001.
Odds of increasing Pros .4 SD on second behavior given .4 SD increase on Pros on the first behavior;
#
Recruited in 1999 in the United States.
aa
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Table 12 presents the participants who progressed to criteria and the coprogression odds ratios for participants who increased their Pros by .4 SD on the second
behavior given a .4 SD increase on Pros on the first behavior compared to participants
who increased their Pros .4 SD on the second behavior but did not increase their Pros .4
SD on the first behavior from baseline to 24-month follow-up for males and females.
Sun Protection and Diet
Results were not significant for males, OR= 1.20 [0.89, 1.63], p < .238, indicating
that although males were slightly more likely to increase their Pros .4 SD on diet given a
.4 SD increase on Pros on sun protection compared to males who made a .4 SD increase
on diet alone, the difference within the White comparison group was not reliable. In
contrast, results were significant for females, OR=1.50 [1.18, 1.93], p < .001, indicating
that females were one and a half times more likely to increase their Pros .4 SD on diet
given a .4 SD increased Pros on sun protection compared to females who increased their
Pros .4 SD on diet alone.
Smoking and Diet
Results were not significant for males, OR= 1.19 [0.64, 2.21], p < .576, or
females, OR=1.50 [0.98, 2.31], p < .065, indicating that although both sexes were more
likely to increase their Pros on diet .4 SD given a .4 SD increased Pros on smoking
compared to their cohort who increased their Pros .4 SD on diet alone, the differences
within each comparison group was not reliable.
Smoking and Sun Protection
Results were not significant for males, OR= 1.41 [0.80, 2.46], p < .232, indicating
that although males were almost one and a half times more likely to increase their Pros .4
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SD on sun protection given a .4 SD increase on Pros on smoking compared to males who
increased their Pros .4 SD on sun protection alone, the difference within the male cohort
was not reliable. In contrast, results were significant for females, OR= 1.50 [1.00, 2.24],
p < .049, indicating that females were one and a half times more likely to increase their
Pros .4 SD on sun protection given a .4 SD increased Pros on smoking compared to
females who increased their Pros .4 SD on sun protection alone.
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Table 12. .4 SD Pros increase on second behavior given .4 SD Pros increase on first behavior by gender;
Co-progression odds ratios from baseline to 24 months#.
Males
Proportion (n/total N)
Confidence Interval

Females
Proportion (n/total N)
Confidence Interval

Participants who increased Pros .4 SD on diet given
a .4 SD increase on Pros for sun protection

.22 (74/340)
[.17, .26]

.27 (128/468)
[.23, .31]

Participants who increased Pros .4 SD on diet given
no .4 SD increase on Pros for sun protection

.19 (175/931)
[.16, .21]

.20 (243/1214)
[.18, .22]

1.20 (0.89, 1.63)

1.50*** (1.18, 1.93)

Participants who increased Pros .4 SD on diet given
a .4 SD increase on Pros for smoking

.23 (18/78)
[.14, .32]

.27 (40/149)
[.20, .34]

Participants who increased Pros .4 SD on diet given
no .4 SD increase on Pros for smoking

.20 (45/224)
[.15, .25]

.20 (87/443)
[.16, .23]

1.19 (0.64, 2.21)

1.50 (0.98, 2.31)

.29 (24/82)
[.19, .39]

.34 (49/144)
[.30, .40]

.23 (58/255)
[.18, .28]

.26 (119/465)
[.21, .30]

1.41 (0.80, 2.46)

1.50** (1.00, 2.24)

Sun Protection & Diet

Co-progression odds ratioa
Smoking & Diet

Co-progression odds ratioa
Smoking & Sun Protection
Participants who increased Pros .4 SD on sun
protection given a .4 SD increase on Pros for
smoking
Participants who increased Pros .4 SD on sun
protection given no .4 SD increase on Pros on
smoking

Co-progression odds ratioa
**

p< .05. *** p< .001.
Odds of increasing Pros .4 SD on second behavior given .4 SD increase on Pros on the first behavior;
#
Recruited in 1999 in the United States.

aa
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CHAPTER 5
CONCLUSIONS
Discussion
Results provide empirical support for the advantages of simultaneous multiple
health behavior change for three very different health behaviors. Specifically, when
smoking, diet, and unprotected sun exposure were analyzed as the three sets of behavior
pairs sun protection and diet, smoking and diet, and smoking and sun protection, results
consistently demonstrated that intervening simultaneously on multiple health behavior
risks increased the likelihood that participants progressed toward healthier outcome
criteria on both behaviors from baseline to 24-month follow-up compared to participants
who only progressed on the second behavior in the behavior pair from baseline to 24month follow-up. Of particular importance is that, as expected, favorable results
occurred across the control, treatment, and total conditions. Moreover, favorable results
were revealed when the outcome was defined by less stringent as well as the most
stringent criteria. That is, when treatment outcomes were defined by stage progress,
reduction in severity, and increased Pros (i.e., less stringent) or defined by meeting
Action/Maintenance (i.e., A/M) criteria (i.e., the most stringent) on both behaviors at 24month follow-up, results consistently demonstrated that simultaneous intervention
increased the likelihood that participants progressed on both behaviors compared to only
making progress only on the second behavior from baseline to 24-month follow-up.
The first hypothesis was supported. The clearest and strongest support occurred
in the sun protection and diet behavior pair analyses which revealed significant and
increased odds ratios in all three conditions. A more modest finding was in the smoking
and sun protection behavior pair analyses which revealed significant and increased odds
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ratios in the overall condition. Although the treatment and control conditions in the
smoking and sun protection behavior pair analyses were not significant, also the case for
all three conditions in the smoking and diet behavior pair analyses, it is worth noting that
all the odds ratios revealed were in the expected and favorable direction. That is, all eight
of the paired action odds ratios demonstrated that participants in later versus earlier SOC
were more likely to progress to A/M on both behaviors compared to progressing to A/M
only the second behavior at 24-month follow-up regardless of the treatment condition.
Additionally, four of the eight results were significant. Thus, the combination of
significant findings and consistent pattern of results in both expected and favorable
directions of the non significant findings lends support to hypothesis one. More
specifically, analyses clearly show that participants in later SOC (i.e., C/PR) at baseline
for multiple health behavior risks were more likely to move to A/M on both behaviors at
24-month follow-up than participants who were in the earliest SOC (i.e., PC) for both
behaviors at baseline.
The second hypothesis was generally supported. The strongest support occurred
in the sun protection and diet behavior pair analyses which revealed significant and
higher co-progression odds ratios in the treatment and overall conditions. Specifically,
findings revealed that participants in the treatment condition were almost two times more
likely to make stage progress on diet given stage progress on sun protection compared to
participants who only made stage progress on diet. In the smoking and diet behavior pair
analyses, participants in the control group were approximately one a half times more
likely to make stage progress on diet given stage progress on smoking while the treatment
group was not significant; a significant finding in the control condition and not in the
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treatment condition provides partial support to this hypothesis. However, modest support
for hypothesis two was found in the smoking and sun protection behavior pair analyses in
that there were higher odds ratios in the treatment versus control condition for
participants to make stage progress on sun protection given stage progress on smoking.
Ultimately, all nine of the co-progression odds ratios demonstrated that participants were
more likely to make stage progress on both behaviors compared to making stage progress
only on the second behavior from baseline to 24-month follow-up regardless of the
treatment condition. Additionally, four of the nine results were significant. Thus, the
significant findings and general pattern of results in both expected and favorable
directions of the non-significant findings lends support for hypothesis two. More
specifically, results clearly provide empirical support for the advantages of coprogression and defining treatment outcome as stage progress from baseline to 24-month
follow-up, a less stringent criterion than paired action defined in hypothesis one.
The third hypothesis was supported. The strongest support occurred in the sun
protection and diet behavior pair analyses with significant results in the total and
treatment conditions, indicating increased likelihood of a reduction on severity on both
sun protection and diet compared to a reduction on severity on diet alone. Significant
results in the total and control conditions for the smoking and diet behavior pair analyses
indicated that participants were just under and over one and a half times more likely to
reduce severity on both smoking and diet compared to a reduction of severity on diet
alone. Ultimately, eight of the nine co-progression odds ratios demonstrated that
participants were more likely to reduce severity on both behaviors compared to reduced
severity only on the second behavior from baseline to 24-month follow-up regardless of
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the treatment condition. Additionally, four of the nine results were significant. Of note,
the only reduced likelihood of progressing on both behaviors compared to the second
behavior was a slightly reduced likelihood and it was not significant. Thus, results
provide empirical support for using reduction in severity as an outcome criterion for
treatment, corroborating reduction in severity as one of the four factors. Furthermore,
and similar to previous findings with MI intervention, results also show that reduction in
severity can be predictive of behavior change at future follow-up time points. Therefore,
in addition to holding treatment outcomes to the most stringent criteria (i.e., A/M)
typically used to establish intervention efficacy and effectiveness, these data suggest that
reduction in severity may be especially important for multiple health behavior change
given the well established difficulty of changing one health risk behavior to A/M criteria,
let alone the difficulty of changing multiple health behavior risks to A/M criteria at the
same time.
The fourth hypothesis was generally supported. Although the first set of planned
analyses proved to be too stringent a criteria to complete as planned, the revised
decisional balance (DB) criteria provided an empirical basis to evaluate the
interrelationships of the Pros of behavior change and multiple behavior change. That is,
increasing Pros by .4 SD from baseline to 24-month follow-up on either or both
behaviors yielded several significant results across the control, treatment, and total
conditions. Specifically, all nine of the co-progression odds ratios were in the predicted
and favorable direction revealing increased likelihood of progressing on both behaviors
compared to progressing only on the second behavior regardless of treatment condition.
Additionally, five of the nine results were significant. This is important because it clearly
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shows that the Pros of DB, long established as important for single health risk behavior
change, is also important to multiple health behavior change. With five significant and
all nine odds ratios all three behavior pairs and treatment conditions, results further
suggest that dynamic variables are critical to the process of multiple health behavior
change. However, additional research is necessary in order to clarify just how the Pros of
behavior change relates to multiple behavior change, and to begin to reveal how
decisional balance (i.e., Pros and Cons) relates to multiple health behavior change.
The fifth hypothesis was generally supported and answered by the analyses and
results of hypothesis one through hypothesis four.
The sixth hypothesis was generally supported. For the stage progress with race
and gender analyses, eight of the twelve results were not significant. Of the significant
findings, there was one for males, one for females, two for Whites, and none for NonWhites. Therefore, there was no clear trend in the data. For the reduction in severity
with race and gender analyses, seven out of the twelve analyses were not significant. Of
the significant findings, there was one for males, two for females, two for Whites and
none for Non-Whites. Again, there was no clear trend in the data. For the Pros with race
and gender analyses, eight out of the twelve results were not significant. Similarly, there
was no clear trend in the data. Altogether, twenty three out of the thirty six analyses (i.e.,
almost two-thirds) of the results were not significant and of the significant findings, there
was no clear trend in the data as results varied by race, gender and treatment condition.
However, further generalization of these results is limited given the demographic
composition of this dataset as discussed in the limitation section. So, as hypothesized,
results did not yield significant differences between race or gender with regard to
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multiple health behavior change whether outcome criteria was defined as paired action or
co-progression from baseline to 24-month follow-up.
Overall, in absolute terms, although there was one more significant finding across
the control conditions compared to the treatment conditions, this research does not
support either condition’s advantage. Taken together, what these results do clearly
suggest is that there are important advantages to simultaneous intervention for multiple
health behavior change whether the intervention is stage-based, computer-tailored
intervention or treatment as usual (TAU) as simultaneous intervention on multiple health
risk behavior accelerated participants toward healthy criteria at outcome regardless of
intervention. However, given SOC and DB are central constructs to the TTM, it seems
the TTM may have a slight advantage in helping to elucidate the science of multiple
health behavior as the model has several dynamic variables which seem relevant to reveal
the interrelationships and synergy that occurs during multiple health behavior change;
although additional research is needed before any firm conclusions can be drawn.
Results of this research recognize that although demographic variables are
important factors to baseline SOC for various health risk behaviors, they are not reliable
predictors of treatment outcome. However, results do provide additional support that the
dynamic variables of SOC, problem severity, and the Pros of DB are reliable predictors
of treatment outcome and that they are important to multiple health behavior change. As
such, this research provides additional support to three of the four factors specifically
(e.g., baseline SOC, DB, and addiction severity) and lends some support to the fourth
factor (i.e., effort) as measured all participants analyzed in this study completed
requirements over a two and a half year time period. What is particularly compelling
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about these results, however, is that the original four factors findings were revealed when
the fundamental unit of analysis was separate health risk behaviors at outcome and these
results were revealed when the fundamental unit of analysis was shifted to behavior pairs
from baseline to 24-month follow-up.
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Limitations
There were several limitations of this research. First, this was a secondary data
analysis and, therefore, all analyses were limited to the existing dataset and its
composition. Although the primary aim of the P01 used for this research project
intervened simultaneously on multiple health behavior risks, making it an ideal dataset to
answer the stated hypotheses, analyzing behavior pairs and calculating paired action and
co-progression odds ratios among treatment, control, and total conditions was not the
primary aim of the original project. Therefore, while analyses compared differences
between treatment and control conditions, conclusions cannot be drawn directly
comparing the two groups to one another. That is, all comparisons in this research
describe the likelihood of participants making progress as defined by outcome criteria
(i.e., paired action or co-progression) that occurred in each treatment condition and not
compared to each treatment condition.
Second, the predominantly White (n=8,503, 93.7%), female (n=5,938, 65.4%),
middle-aged recruitment solely from a Northeastern state presents certain limitations as
well. For example, with race, such a large sample of Whites likely provided sufficient
power to find significant differences in the analyses between Whites who met criteria
(i.e., progressed on the second behavior given progress on the first behavior) compared to
Whites who did not (i.e., who only made progress on the second behavior) versus NonWhites which had a very small sample size. So, this may help explain why the sun
protection and diet and the smoke and diet analyses was significant for Whites, but not
significant for Non-Whites because there would have to be a very large effect size in
order for the analyses to detect a significant difference in the Non-Whites group. Also,
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and consistent with the literature that race affects baseline SOC for health risk behaviors,
race may also have affected all the analyses involving sun protection. Specifically, fairer
skin Whites, who are at greater risk for unprotected sun exposure than darker skin
Whites, may have a different baseline SOC from one another. Similarly, Non-Whites,
who are at lower risk of unprotected sun exposure, may have a different SOC due to the
reduced risk on this behavior. Moreover, with such a small sample sizes for Non-Whites,
this research recoded race as Whites and Non-Whites, an amalgamation of all Non-White
races, ignoring important and possible variability between and within each group,
respectively.
Third, the sample size mean age was 43-years-old with a standard deviation of ten
years. Therefore, 68% of the sample ranged from 33 to 53-years-old and 96% of the
sample ranged from 23 to 63-years-old. Given the physical, cognitive, and social
differences between middle-aged adults and other age groups, it is unclear how these
results generalize to other populations and demographics. For example, it is unclear how
the normative stressors associated with middle adulthood (e.g., balancing marriage,
parenting, family, career, finances, aging parents, etc.), quite distinct from other
developmental stages (e.g., childhood, adolescence, late adulthood, very old age), may
affect the processes of change for multiple health behavior change. That is, it is not clear
how reduced harm or the Pros of behavior change may vary by lifespan development.
Fourth, all the participants were recruited from a Northeastern state. As such,
results may not generalize to other regions of the country given possible geographic
differences with other parts of the country. Another limitation of sample’s recruitment is
that the Northeast has considerable seasonal variability and it is not clear how this may
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have affected baseline and follow-up SOC for unprotected sun exposure. Specifically,
the summer has a higher risk of unprotected sun exposure for all races and both genders,
but more so for Whites than Non-Whites, while the winter has a much lower risk for all
races and both genders. This temporal dimension was not accounted for by the analyses
conducted in this research. Therefore, its effect is unknown.
There were several other limitations to this project as well. The inability to
complete all the planned analyses due to insufficient sample size and stringent criteria for
the strong and weak principles for the behavior pairs obviated the opportunity to conduct
analyses on decisional balance or the strong and weak principles for behavior pairs as has
been established for separate behaviors. Therefore, this project did not address these
important gaps in the literature. In addition, because of the cumulative nature of some of
the hypotheses, some of the analyses were not able to be performed throughout the
project as observed in the strong and weak principles for race and gender (i.e., hypothesis
six). Another limitation is that decisional balance measure (i.e., the Pros and Cons) for
sun exposure was a 20-item Likert-scale. However, decisional balance for smoking and
diet were both assessed on a 5-item Likert-scale. Although this was accounted for in
calculating the mean and standard deviations for each behavior in each of the treatment
conditions, it is not clear how a 20-item Likert-scale for sun exposure and two 5-item
Likert scales for smoking and diet may have affected participants’ responses.
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Summary
Results provide empirical support for the advantages of simultaneous intervention
for multiple health behavior change as paired action, co-progression, and reduction in
severity was observed across the control, treatment and total conditions. With
approximately an equal amount of significant findings across the control and treatment
conditions for paired action, co-progression, and reduction on severity, results do not
support either condition’s advantage. However, taken together, results do provide
empirical support for the advantages and synergistic effect when intervening on multiple
health behavior risks simultaneously, in addition to demonstrating the importance and
value of the most stringent (i.e., A/M) as well as less stringent (i.e., stage progress,
reduction of severity) outcome criteria when elucidating the science of behavior change.
Results further suggest that simultaneous intervention targeting multiple health
behavior risks for three very different behaviors increases the likelihood that participants
will accelerate stage progress toward healthier behavioral lifestyles, including smoking
cessation, healthy diet, and reduced risk for unprotected sun exposure. Results of this
research do not suggest that simultaneous intervention on multiple health behavior risks
is too taxing, stressful, or difficult which would have been revealed with paired action or
co-progression odds ratios lower than 1.0 in any of the behavior pair analyses across any
of the treatment conditions. In fact, only one out of the 71 odds ratios revealed a lower
likelihood of progressing toward favorable and healthier outcome criteria whether in the
most or less stringent outcome criteria analyses. Specifically, the only exception was an
odds ratio of .94 for the smoking and diet behavior pair analyses in the treatment
condition for reduction in severity; however, this odds ratio was not significant. Finally,
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results do provide empirical support for shifting the fundamental unit of analysis from
separate behaviors at outcome to behavior pairs at outcome.
Recommendations for future research include efficacy trials to systematically
evaluate the difference between treatment-enhanced and naturally occurring paired action
and co-progression. Research could also broaden the behavior pairs of analysis to
investigate many other problem areas which bear directly on mortality, quality of life and
health care costs. Although numerous examples abound, one specific example would be
to further understand the intricacies and interrelationships between medication adherence,
diet, exercise, and substance abuse (e.g., smoking, alcohol) with diabetics. Such
advancements could provide invaluable information to help advance, inform, and guide
integrated treatment as well as prevention research. Of course, this is just a few of the
behavior pair analyses that could help provide valuable contributions to the management,
treatment, and prevention of many other chronic medical conditions such as
cardiovascular disease and some cancers. With countless other examples critical to
issues of quality of life, disease management and prevention, healthcare costs, and public
policy, continued research on multiple health behavior change is of paramount
importance. Such efforts will not only help elucidate the science of behavior change, but
will also help guide the future of research and practice toward an integrative model of
multiple health behavior change.
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APPENDIX
Appendix 1
1)

The original hypothesis, “participants who decrease their severity by a defined

amount on one behavior (i.e., cutting back by a certain percentage of cigarettes per day)
will also reduce their severity on other behaviors, with more co-progression observed in
the treatment group than the control group” was slightly modified given data analytic
problems. Similar to previous analyses, the independent and dependent variables were
analyzed by the same three behavior pairs: sun protection and diet, smoking and diet, and
smoking and sun protection. Specifically, the independent variable was the participant’s
number of cigarettes smoked, diet total score, and sun protection total score at baseline
and the dependent variable was whether the participant reduced their smoking habit by
50% from baseline to 24-month follow-up, either yes or no, and whether they progressed
to A/M on diet, either yes or no, and whether they progressed to A/M on sun protection,
either yes or no, at 24-month follow-up. Given so few participants (i.e., sometimes zero)
met this criteria, analyses could not be completed as planned. Therefore, this hypothesis
was slightly revised and described and presented in hypothesis 3.
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